Journal Article
. 2015 May;26(8).
doi: 10.1093/annonc/mdv221.

Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

A S Coates 1 E P Winer 2 A Goldhirsch 3 R D Gelber 4 M Gnant 5 M Piccart-Gebhart 6 B Thürlimann 7 H-J Senn 8 Panel Members  
Affiliations
  • PMID: 25939896
  •     93 References
  •     456 citations

Abstract

The 14th St Gallen International Breast Cancer Conference (2015) reviewed substantial new evidence on locoregional and systemic therapies for early breast cancer. Further experience has supported the adequacy of tumor margins defined as 'no ink on invasive tumor or DCIS' and the safety of omitting axillary dissection in specific cohorts. Radiotherapy trials support irradiation of regional nodes in node-positive disease. Considering subdivisions within luminal disease, the Panel was more concerned with indications for the use of specific therapies, rather than surrogate identification of intrinsic subtypes as measured by multiparameter molecular tests. For the treatment of HER2-positive disease in patients with node-negative cancers up to 1 cm, the Panel endorsed a simplified regimen comprising paclitaxel and trastuzumab without anthracycline as adjuvant therapy. For premenopausal patients with endocrine responsive disease, the Panel endorsed the role of ovarian function suppression with either tamoxifen or exemestane for patients at higher risk. The Panel noted the value of an LHRH agonist given during chemotherapy for premenopausal women with ER-negative disease in protecting against premature ovarian failure and preserving fertility. The Panel noted increasing evidence for the prognostic value of commonly used multiparameter molecular markers, some of which also carried prognostic information for late relapse. The Panel noted that the results of such tests, where available, were frequently used to assist decisions about the inclusion of cytotoxic chemotherapy in the treatment of patients with luminal disease, but noted that threshold values had not been established for this purpose for any of these tests. Multiparameter molecular assays are expensive and therefore unavailable in much of the world. The majority of new breast cancer cases and breast cancer deaths now occur in less developed regions of the world. In these areas, less expensive pathology tests may provide valuable information. The Panel recommendations on treatment are not intended to apply to all patients, but rather to establish norms appropriate for the majority. Again, economic considerations may require that less expensive and only marginally less effective therapies may be necessary in less resourced areas. Panel recommendations do not imply unanimous agreement among Panel members. Indeed, very few of the 200 questions received 100% agreement from the Panel. In the text below, wording is intended to convey the strength of Panel support for each recommendation, while details of Panel voting on each question are available in supplementary Appendix S2, available at Annals of Oncology online.

Keywords: St Gallen Consensus; early breast cancer; radiation therapy; surgery; systemic adjuvant therapies.

An international study to increase concordance in Ki67 scoring.
Mei-Yin C Polley, Samuel C Y Leung, +28 authors, Torsten O Nielsen.
Mod Pathol, 2015 Feb 24; 28(6). PMID: 25698062
Highly Cited.
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105.
Melinda L Telli, Kristin C Jensen, +18 authors, James M Ford.
J Clin Oncol, 2015 Apr 08; 33(17). PMID: 25847929    Free PMC article.
Highly Cited.
Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy.
Lynn T Dengel, Kimberly J Van Zee, +12 authors, Monica Morrow.
Ann Surg Oncol, 2013 Aug 27; 21(1). PMID: 23975314    Free PMC article.
Research-based PAM50 subtype predictor identifies higher responses and improved survival outcomes in HER2-positive breast cancer in the NOAH study.
Aleix Prat, Giampaolo Bianchini, +13 authors, José Baselga.
Clin Cancer Res, 2014 Jan 21; 20(2). PMID: 24443618
Highly Cited.
Reply to Ki67 in breast cancer: a useful prognostic marker!
C Denkert, G von Minckwitz.
Ann Oncol, 2014 Jan 17; 25(2). PMID: 24431345
High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial.
G Viale, L Slaets, +11 authors, TRANSBIG Consortium & the MINDACT Investigators.
Ann Oncol, 2014 Mar 29; 25(4). PMID: 24667714    Free PMC article.
Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011.
Allison W Kurian, Daphne Y Lichtensztajn, +3 authors, Scarlett L Gomez.
JAMA, 2014 Sep 04; 312(9). PMID: 25182099    Free PMC article.
Highly Cited.
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response.
Evandro de Azambuja, Andrew P Holmes, +24 authors, José Baselga.
Lancet Oncol, 2014 Aug 19; 15(10). PMID: 25130998
Highly Cited.
Molecular subtyping predicts pathologic tumor response in early-stage breast cancer treated with neoadjuvant docetaxel plus capecitabine with or without trastuzumab chemotherapy.
Soley Bayraktar, Melanie Royce, +2 authors, Stefan Glück.
Med Oncol, 2014 Sep 05; 31(10). PMID: 25186065
PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancer.
Sibylle Loibl, Gunter von Minckwitz, +22 authors, Carsten Denkert.
J Clin Oncol, 2014 Sep 10; 32(29). PMID: 25199759
Highly Cited.
Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors.
J-C Soria, F DeBraud, +15 authors, J Tabernero.
Ann Oncol, 2014 Sep 07; 25(11). PMID: 25193991
Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes.
Patrick Maisonneuve, Davide Disalvatore, +10 authors, Aron Goldhirsch.
Breast Cancer Res, 2014 Jun 22; 16(3). PMID: 24951027    Free PMC article.
Evaluating the predictive value of biomarkers for efficacy outcomes in response to pertuzumab- and trastuzumab-based therapy: an exploratory analysis of the TRYPHAENA study.
Andreas Schneeweiss, Stephen Chia, +7 authors, Javier Cortés.
Breast Cancer Res, 2014 Jul 10; 16(4). PMID: 25005255    Free PMC article.
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.
Roy S Herbst, Jean-Charles Soria, +19 authors, F Stephen Hodi.
Nature, 2014 Nov 28; 515(7528). PMID: 25428504    Free PMC article.
Highly Cited.
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.
Mila Donker, Geertjan van Tienhoven, +27 authors, Emiel J T Rutgers.
Lancet Oncol, 2014 Dec 03; 15(12). PMID: 25439688    Free PMC article.
Highly Cited.
Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.
Sylvia Adams, Robert J Gray, +13 authors, Sunil S Badve.
J Clin Oncol, 2014 Jul 30; 32(27). PMID: 25071121    Free PMC article.
Highly Cited.
Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology Group.
Amye J Tevaarwerk, Molin Wang, +9 authors, Nicholas J Robert.
J Clin Oncol, 2014 Oct 29; 32(35). PMID: 25349302    Free PMC article.
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance).
William M Sikov, Donald A Berry, +14 authors, Eric P Winer.
J Clin Oncol, 2014 Aug 06; 33(1). PMID: 25092775    Free PMC article.
Highly Cited.
Atypical hyperplasia of the breast--risk assessment and management options.
Lynn C Hartmann, Amy C Degnim, +2 authors, Karthik Ghosh.
N Engl J Med, 2015 Jan 01; 372(1). PMID: 25551530    Free PMC article.
Highly Cited.
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.
Sara M Tolaney, William T Barry, +16 authors, Eric P Winer.
N Engl J Med, 2015 Jan 08; 372(2). PMID: 25564897    Free PMC article.
Highly Cited.
Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study.
Jean-Francois Boileau, Brigitte Poirier, +16 authors, Andre Robidoux.
J Clin Oncol, 2014 Dec 03; 33(3). PMID: 25452445
Highly Cited.
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12.
M Gnant, B Mlineritsch, +23 authors, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria.
Ann Oncol, 2014 Nov 19; 26(2). PMID: 25403582
Adjuvant ovarian suppression in premenopausal breast cancer.
Prudence A Francis, Meredith M Regan, +28 authors, International Breast Cancer Study Group.
N Engl J Med, 2014 Dec 17; 372(5). PMID: 25495490    Free PMC article.
Highly Cited.
Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience.
Antonio C Wolff, Amanda L Blackford, +10 authors, Judith E Karp.
J Clin Oncol, 2014 Dec 24; 33(4). PMID: 25534386    Free PMC article.
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.
Richard S Finn, John P Crown, +15 authors, Dennis J Slamon.
Lancet Oncol, 2014 Dec 20; 16(1). PMID: 25524798
Highly Cited.
Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors.
L Eckhoff, As Knoop, M B Jensen, M Ewertz.
Eur J Cancer, 2014 Dec 30; 51(3). PMID: 25541155
Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance).
Judy C Boughey, Vera J Suman, +9 authors, Alliance for Clinical Trials in Oncology.
Ann Surg, 2015 Feb 11; 261(3). PMID: 25664534    Free PMC article.
Impact of multifocal or multicentric disease on surgery and locoregional, distant and overall survival of 6,134 breast cancer patients treated with neoadjuvant chemotherapy.
Beyhan Ataseven, Bianca Lederer, +8 authors, Gunter von Minckwitz.
Ann Surg Oncol, 2014 Oct 10; 22(4). PMID: 25297900
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.
Halle C F Moore, Joseph M Unger, +22 authors, POEMS/S0230 Investigators.
N Engl J Med, 2015 Mar 05; 372(10). PMID: 25738668    Free PMC article.
Highly Cited.
Prediction of late distant recurrence after 5 years of endocrine treatment: a combined analysis of patients from the Austrian breast and colorectal cancer study group 8 and arimidex, tamoxifen alone or in combination randomized trials using the PAM50 risk of recurrence score.
Ivana Sestak, Jack Cuzick, +8 authors, Michael Gnant.
J Clin Oncol, 2014 Oct 22; 33(8). PMID: 25332252
Highly Cited.
A bad tumor biomarker is as bad as a bad drug: The gap between genomics data and phenotype to predict response.
Giuseppe Viale.
Breast, 2015 Aug 11; 24 Suppl 2. PMID: 26255744
Neoadjuvant endocrine therapy: Patient selection, treatment duration and surrogate endpoints.
Belinda Yeo, Mitch Dowsett.
Breast, 2015 Aug 11; 24 Suppl 2. PMID: 26255746
Defining optimal duration and predicting benefit from chemotherapy in patients with luminal-like subtypes.
Christopher D Hart, Giuseppina Sanna, +2 authors, Angelo Di Leo.
Breast, 2015 Sep 01; 24 Suppl 2. PMID: 26320761
Review.
PIK3CA mutations are associated with decreased benefit to neoadjuvant human epidermal growth factor receptor 2-targeted therapies in breast cancer.
Ian J Majewski, Paolo Nuciforo, +18 authors, José Baselga.
J Clin Oncol, 2015 Jan 07; 33(12). PMID: 25559818    Free PMC article.
Highly Cited.
PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.
Roy R L Bastien, Álvaro Rodríguez-Lescure, +29 authors, Miguel Martín.
BMC Med Genomics, 2012 Oct 06; 5. PMID: 23035882    Free PMC article.
Highly Cited.
Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101.
Lawrence N Shulman, Constance T Cirrincione, +12 authors, Clifford Hudis.
J Clin Oncol, 2012 Jul 25; 30(33). PMID: 22826271    Free PMC article.
Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer.
Aleix Prat, Maggie Chon U Cheang, +8 authors, Charles M Perou.
J Clin Oncol, 2012 Dec 13; 31(2). PMID: 23233704    Free PMC article.
Highly Cited.
The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use.
W Eiermann, M Rezai, +13 authors, J Blohmer.
Ann Oncol, 2012 Nov 09; 24(3). PMID: 23136233    Free PMC article.
Molecular characterization of basal-like and non-basal-like triple-negative breast cancer.
Aleix Prat, Barbara Adamo, +3 authors, Charles M Perou.
Oncologist, 2013 Feb 14; 18(2). PMID: 23404817    Free PMC article.
Highly Cited. Review.
Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer.
G Allevi, C Strina, +15 authors, D Generali.
Br J Cancer, 2013 Apr 13; 108(8). PMID: 23579222    Free PMC article.
Evolution of sites of recurrence after early breast cancer over the last 20 years: implications for patient care and future research.
N Bouganim, E Tsvetkova, M Clemons, E Amir.
Breast Cancer Res Treat, 2013 May 18; 139(2). PMID: 23681402
Review.
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.
Thorsten Kuehn, Ingo Bauerfeind, +11 authors, Michael Untch.
Lancet Oncol, 2013 May 21; 14(7). PMID: 23683750
Highly Cited.
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Christina Davies, Hongchao Pan, +36 authors, Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group.
Lancet, 2012 Dec 12; 381(9869). PMID: 23219286    Free PMC article.
Highly Cited.
Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer.
Fabrice André, Thomas Bachelot, +13 authors, José Baselga.
Clin Cancer Res, 2013 May 10; 19(13). PMID: 23658459
Highly Cited.
Effect of age on breast cancer outcomes in women with human epidermal growth factor receptor 2-positive breast cancer: results from a herceptin adjuvant trial.
Ann H Partridge, Shari Gelber, +5 authors, Richard D Gelber.
J Clin Oncol, 2013 Jun 12; 31(21). PMID: 23752109
Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy.
Mitch Dowsett, Ivana Sestak, +7 authors, Jack Cuzick.
J Clin Oncol, 2013 Jul 03; 31(22). PMID: 23816962
Highly Cited.
Breast cancer index identifies early-stage estrogen receptor-positive breast cancer patients at risk for early- and late-distant recurrence.
Yi Zhang, Catherine A Schnabel, +7 authors, Mark G Erlander.
Clin Cancer Res, 2013 Jun 13; 19(15). PMID: 23757354
ASCO's approach to a learning health care system in oncology.
George W Sledge, Clifford A Hudis, +4 authors, Allen S Lichter.
J Oncol Pract, 2013 Aug 15; 9(3). PMID: 23942494    Free PMC article.
Review.
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA).
A Schneeweiss, S Chia, +10 authors, J Cortés.
Ann Oncol, 2013 May 25; 24(9). PMID: 23704196
Highly Cited.
Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.
Kelly-Anne Phillips, Roger L Milne, +33 authors, John L Hopper.
J Clin Oncol, 2013 Aug 07; 31(25). PMID: 23918944    Free PMC article.
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.
Joanne S Haviland, J Roger Owen, +14 authors, START Trialists' Group.
Lancet Oncol, 2013 Sep 24; 14(11). PMID: 24055415
Highly Cited.
Factors predicting late recurrence for estrogen receptor-positive breast cancer.
Ivana Sestak, Mitch Dowsett, +4 authors, Jack Cuzick.
J Natl Cancer Inst, 2013 Sep 14; 105(19). PMID: 24029245    Free PMC article.
Highly Cited.
Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes.
Hiroko Masuda, Keith A Baggerly, +9 authors, Naoto T Ueno.
Clin Cancer Res, 2013 Aug 21; 19(19). PMID: 23948975    Free PMC article.
Highly Cited.
Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial.
C Denkert, S Loibl, +17 authors, G von Minckwitz.
Ann Oncol, 2013 Aug 24; 24(11). PMID: 23970015
Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998-2002.
Katharine Yao, David J Winchester, Tomasz Czechura, Dezheng Huo.
Breast Cancer Res Treat, 2013 Nov 13; 142(3). PMID: 24218052
Review.
The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients.
P Dubsky, J C Brase, +18 authors, Austrian Breast and Colorectal Cancer Study Group (ABCSG).
Br J Cancer, 2013 Oct 26; 109(12). PMID: 24157828    Free PMC article.
Highly Cited.
An international Ki67 reproducibility study.
Mei-Yin C Polley, Samuel C Y Leung, +16 authors, International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group.
J Natl Cancer Inst, 2013 Nov 10; 105(24). PMID: 24203987    Free PMC article.
Highly Cited.
High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in luminal B HER2 negative and node-positive breast cancer.
Carmen Criscitiello, Davide Disalvatore, +12 authors, Giuseppe Curigliano.
Breast, 2013 Dec 10; 23(1). PMID: 24314620
Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers.
Carsten Denkert, Gunter von Minckwitz, +27 authors, Sibylle Loibl.
J Clin Oncol, 2014 Dec 24; 33(9). PMID: 25534375
Highly Cited.
Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens.
Torsten Nielsen, Brett Wallden, +7 authors, James Storhoff.
BMC Cancer, 2014 Mar 15; 14. PMID: 24625003    Free PMC article.
Highly Cited.
The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer.
Angela DeMichele, Douglas Yee, +39 authors, Laura J Esserman.
Clin Cancer Res, 2015 Feb 26; 21(13). PMID: 25712686    Free PMC article.
Standardized Ki67 Diagnostics Using Automated Scoring--Clinical Validation in the GeparTrio Breast Cancer Study.
Frederick Klauschen, Stephan Wienert, +11 authors, Gunter von Minckwitz.
Clin Cancer Res, 2014 Dec 17; 21(16). PMID: 25501130
Hypofractionated radiotherapy in early breast cancer: Clinical, dosimetric and radio-genomic issues.
John Yarnold, Navita Somaiah, Judith M Bliss.
Breast, 2015 Aug 08; 24 Suppl 2. PMID: 26249121
Which threshold for ER positivity? a retrospective study based on 9639 patients.
M Yi, L Huo, +11 authors, K K Hunt.
Ann Oncol, 2014 Feb 25; 25(5). PMID: 24562447    Free PMC article.
Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer.
Meena S Moran, Stuart J Schnitt, +11 authors, American Society for Radiation Oncology.
J Clin Oncol, 2014 Feb 12; 32(14). PMID: 24516019
Highly Cited. Systematic Review.
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial.
Gunter von Minckwitz, Andreas Schneeweiss, +23 authors, Michael Untch.
Lancet Oncol, 2014 May 06; 15(7). PMID: 24794243
Highly Cited.
Margins in breast conservation: a clinician's perspective and what the literature tells us.
Nehmat Houssami, Monica Morrow.
J Surg Oncol, 2014 Apr 24; 110(1). PMID: 24756965
Review.
Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX.
Alan S Coates, Ewan K A Millar, +10 authors, Robert L Sutherland.
Breast Cancer Res, 2012 Nov 07; 14(6). PMID: 23127292    Free PMC article.
An epigenomic approach to therapy for tamoxifen-resistant breast cancer.
Qin Feng, Zheng Zhang, +15 authors, Bert W O'Malley.
Cell Res, 2014 May 31; 24(7). PMID: 24874954    Free PMC article.
Highly Cited.
Trastuzumab-associated cardiac events at 8 years of median follow-up in the Herceptin Adjuvant trial (BIG 1-01).
Evandro de Azambuja, Marion J Procter, +15 authors, Thomas M Suter.
J Clin Oncol, 2014 Jun 11; 32(20). PMID: 24912899
Highly Cited.
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.
Olivia Pagani, Meredith M Regan, +32 authors, International Breast Cancer Study Group.
N Engl J Med, 2014 Jun 03; 371(2). PMID: 24881463    Free PMC article.
Highly Cited.
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial.
S Loi, S Michiels, +13 authors, C Sotiriou.
Ann Oncol, 2014 Mar 13; 25(8). PMID: 24608200
Highly Cited.
CT-planned internal mammary node radiotherapy in the DBCG-IMN study: benefit versus potentially harmful effects.
Lise B J Thorsen, Mette S Thomsen, +7 authors, Danish Breast Cancer Cooperative Group Radiotherapy committee.
Acta Oncol, 2014 Jun 25; 53(8). PMID: 24957557
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, +14 authors, A L Børresen-Dale.
Proc Natl Acad Sci U S A, 2001 Sep 13; 98(19). PMID: 11553815    Free PMC article.
Highly Cited.
Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.
Mitch Dowsett, Ian E Smith, +8 authors, IMPACT Trialists Group.
J Natl Cancer Inst, 2007 Jan 18; 99(2). PMID: 17228000
Highly Cited.
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients.
E de Azambuja, F Cardoso, +7 authors, M Paesmans.
Br J Cancer, 2007 Apr 25; 96(10). PMID: 17453008    Free PMC article.
Highly Cited.
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
M M Regan, O Pagani, +12 authors, SOFT/TEXT/PERCHE Steering Committee and the International Breast Cancer Study Group.
Ann Oncol, 2008 Mar 08; 19(7). PMID: 18325918
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.
Pratyaksha Wirapati, Christos Sotiriou, +10 authors, Mauro Delorenzi.
Breast Cancer Res, 2008 Jul 30; 10(4). PMID: 18662380    Free PMC article.
Highly Cited.
Long-term results of hypofractionated radiation therapy for breast cancer.
Timothy J Whelan, Jean-Philippe Pignol, +12 authors, Carolyn Freeman.
N Engl J Med, 2010 Feb 12; 362(6). PMID: 20147717
Highly Cited.
A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer.
Torsten O Nielsen, Joel S Parker, +12 authors, Matthew J Ellis.
Clin Cancer Res, 2010 Sep 15; 16(21). PMID: 20837693    Free PMC article.
Highly Cited.
Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.
Armando E Giuliano, Kelly K Hunt, +7 authors, Monica Morrow.
JAMA, 2011 Feb 10; 305(6). PMID: 21304082    Free PMC article.
Highly Cited.
Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study.
Bernd Gerber, Gunter von Minckwitz, +12 authors, German Breast Group Investigators.
J Clin Oncol, 2011 May 04; 29(17). PMID: 21537042
The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer.
Steven A Narod.
Breast Cancer Res Treat, 2011 Apr 02; 128(2). PMID: 21455666
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.
Brian D Lehmann, Joshua A Bauer, +4 authors, Jennifer A Pietenpol.
J Clin Invest, 2011 Jun 03; 121(7). PMID: 21633166    Free PMC article.
Highly Cited.
Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.
Lucia Del Mastro, Luca Boni, +14 authors, Marco Venturini.
JAMA, 2011 Jul 21; 306(3). PMID: 21771987
Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial.
G Viale, M M Regan, +17 authors, BIG 1-98 Collaborative and International Breast Cancer Study Groups.
Ann Oncol, 2011 Feb 22; 22(10). PMID: 21335417    Free PMC article.
Adjuvant trastuzumab in HER2-positive breast cancer.
Dennis Slamon, Wolfgang Eiermann, +21 authors, Breast Cancer International Research Group.
N Engl J Med, 2011 Oct 14; 365(14). PMID: 21991949    Free PMC article.
Highly Cited.
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), R Peto, +15 authors, K Pritchard.
Lancet, 2011 Dec 14; 379(9814). PMID: 22152853    Free PMC article.
Highly Cited.
Increasing rates of contralateral prophylactic mastectomy - a trend made in USA?
U Güth, M E Myrick, +3 authors, S M Schmid.
Eur J Surg Oncol, 2012 Feb 07; 38(4). PMID: 22305274
Comprehensive molecular portraits of human breast tumours.
Cancer Genome Atlas Network.
Nature, 2012 Sep 25; 490(7418). PMID: 23000897    Free PMC article.
Highly Cited.
Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer.
Carla S Milagre, Ganga Gopinathan, +8 authors, Frances R Balkwill.
Cancer Res, 2015 Feb 12; 75(7). PMID: 25670170    Free PMC article.
Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?
Olivia Pagani, Monica Ruggeri, +20 authors, Ann H Partridge.
Breast, 2015 Feb 11; 24(3). PMID: 25662412
No clear effect of postoperative radiotherapy on survival of breast cancer patients with one to three positive nodes: a population-based study.
A E Nordenskjöld, H Fohlin, +6 authors, P Karlsson.
Ann Oncol, 2015 Apr 04; 26(6). PMID: 25839671
Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease.
Aron Goldhirsch, Marco Colleoni, Meredith Regan.
Ecancermedicalscience, 2015 Jun 18; 9. PMID: 26082801    Free PMC article.
Review.
Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015).
M Untch, N Harbeck, +22 authors, S Loibl.
Geburtshilfe Frauenheilkd, 2015 Jul 15; 75(6). PMID: 26166836    Free PMC article.
Review.
Toolbox to Reduce Lumpectomy Reoperations and Improve Cosmetic Outcome in Breast Cancer Patients: The American Society of Breast Surgeons Consensus Conference.
Jeffrey Landercasper, Deanna Attai, +18 authors, Hiram Cody.
Ann Surg Oncol, 2015 Jul 29; 22(10). PMID: 26215198    Free PMC article.
Progress in adjuvant chemotherapy for breast cancer: an overview.
Jesus Anampa, Della Makower, Joseph A Sparano.
BMC Med, 2015 Aug 19; 13. PMID: 26278220    Free PMC article.
Highly Cited. Review.
Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in Survivors.
Zeev Blumenfeld, Hilli Zur, Eldad J Dann.
Oncologist, 2015 Oct 16; 20(11). PMID: 26463871    Free PMC article.
Early-Stage Breast Cancer in the Elderly: Confronting an Old Clinical Problem.
Fotinos-Ioannis D Dimitrakopoulos, Anastasia Kottorou, +2 authors, Haralabos P Kalofonos.
J Breast Cancer, 2015 Oct 17; 18(3). PMID: 26472970    Free PMC article.
Review.
Defining lymphocyte-predominant breast cancer by the proportion of lymphocyte-rich stroma and its significance in routine histopathological diagnosis.
Haruo Ohtani, Kazuko Mori-Shiraishi, Morio Nakajima, Hamaichi Ueki.
Pathol Int, 2015 Nov 05; 65(12). PMID: 26530981    Free PMC article.
14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts.
Christian Jackisch, Nadia Harbeck, +22 authors, Michael Untch.
Breast Care (Basel), 2015 Nov 12; 10(3). PMID: 26557827    Free PMC article.
Nuclear PARP1 expression and its prognostic significance in breast cancer patients.
Annalisa Mazzotta, Giulia Partipilo, +3 authors, Anita Mangia.
Tumour Biol, 2015 Nov 29; 37(5). PMID: 26614429
FGFR1 is an adverse outcome indicator for luminal A breast cancers.
Yu-Jie Shi, Julia Y S Tsang, +3 authors, Gary M Tse.
Oncotarget, 2015 Dec 18; 7(4). PMID: 26673008    Free PMC article.
Chemotherapy in Premenopausal Breast Cancer Patients.
Ann H Partridge.
Breast Care (Basel), 2015 Dec 22; 10(5). PMID: 26688676    Free PMC article.
Review.
The Modern Landscape of Endocrine Therapy for Premenopausal Women with Breast Cancer.
Lorenzo Rossi, Olivia Pagani.
Breast Care (Basel), 2015 Dec 22; 10(5). PMID: 26688677    Free PMC article.
Review.
FOXA1 expression affects the proliferation activity of luminal breast cancer stem cell populations.
Kana Tachi, Akira Shiraishi, +5 authors, Osamu Ohneda.
Cancer Sci, 2015 Dec 29; 107(3). PMID: 26708273    Free PMC article.
Ki67--An unsuitable marker of gastric cancer prognosis unmasks intratumoral heterogeneity.
Christine Böger, Hans-Michael Behrens, Christoph Röcken.
J Surg Oncol, 2015 Dec 29; 113(1). PMID: 26709194    Free PMC article.
Cancer and fertility preservation: international recommendations from an expert meeting.
Matteo Lambertini, Lucia Del Mastro, +13 authors, Paola Anserini.
BMC Med, 2016 Jan 06; 14. PMID: 26728489    Free PMC article.
Highly Cited.
Association between HER2 status and response to neoadjuvant anthracycline followed by paclitaxel plus carboplatin chemotherapy without trastuzumab in breast cancer.
Lu Yao, Juan Zhang, +7 authors, Yuntao Xie.
Chin J Cancer Res, 2016 Jan 12; 27(6). PMID: 26752929    Free PMC article.
Sentinel lymph nodes for breast carcinoma: an update on current practice.
Aoife Maguire, Edi Brogi.
Histopathology, 2016 Jan 16; 68(1). PMID: 26768036    Free PMC article.
Review.
A time and motion study of subcutaneous versus intravenous trastuzumab in patients with HER2-positive early breast cancer.
Erwin De Cock, Xavier Pivot, +4 authors, Ann Knoop.
Cancer Med, 2016 Jan 26; 5(3). PMID: 26806010    Free PMC article.
The use of postoperative radiation after nipple sparing mastectomy.
Roberto Orecchia.
Gland Surg, 2016 Feb 09; 5(1). PMID: 26855910    Free PMC article.
Review.
Targeted therapies with companion diagnostics in the management of breast cancer: current perspectives.
Meagan B Myers.
Pharmgenomics Pers Med, 2016 Feb 10; 9. PMID: 26858530    Free PMC article.
Review.
Current status of ultrasound-guided surgery in the treatment of breast cancer.
José H Volders, Max H Haloua, +2 authors, Petrousjka M van den Tol.
World J Clin Oncol, 2016 Feb 11; 7(1). PMID: 26862490    Free PMC article.
Review.
Digital image analysis outperforms manual biomarker assessment in breast cancer.
Gustav Stålhammar, Nelson Fuentes Martinez, +9 authors, Johan Hartman.
Mod Pathol, 2016 Feb 27; 29(4). PMID: 26916072
The Value of 18F-FDG PET/CT Imaging Combined With Pretherapeutic Ki67 for Early Prediction of Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.
Jurui Luo, Zhirui Zhou, +7 authors, Xiaoli Yu.
Medicine (Baltimore), 2016 Mar 05; 95(8). PMID: 26937935    Free PMC article.
Risk Factors Associated with Discordant Ki-67 Levels between Preoperative Biopsy and Postoperative Surgical Specimens in Breast Cancers.
Hyung Sun Kim, Seho Park, +6 authors, Byeong-Woo Park.
PLoS One, 2016 Mar 10; 11(3). PMID: 26954364    Free PMC article.
Breast segmentectomy with rotation mammoplasty as an oncoplastic approach to extensive ductal carcinoma in situ.
Bartlomiej Szynglarewicz, Adam Maciejczyk, Jozef Forgacz, Rafal Matkowski.
World J Surg Oncol, 2016 Mar 10; 14. PMID: 26956623    Free PMC article.
The Metabolism, Analysis, and Targeting of Steroid Hormones in Breast and Prostate Cancer.
Cameron P Capper, James M Rae, Richard J Auchus.
Horm Cancer, 2016 Mar 13; 7(3). PMID: 26969590    Free PMC article.
Review.
Prognostic implications of securin expression and sub-cellular localization in human breast cancer.
N Gurvits, H Repo, +5 authors, P Kronqvist.
Cell Oncol (Dordr), 2016 Mar 18; 39(4). PMID: 26984614
Breast Cancer Is Our Global Responsibility.
Nadia Harbeck, Michael Gnant, Christoph Thomssen.
Breast Care (Basel), 2016 Mar 19; 10(6). PMID: 26989353    Free PMC article.
Translating RNA sequencing into clinical diagnostics: opportunities and challenges.
Sara A Byron, Kendall R Van Keuren-Jensen, +2 authors, David W Craig.
Nat Rev Genet, 2016 Mar 22; 17(5). PMID: 26996076    Free PMC article.
Highly Cited. Review.
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer.
Luisa Carbognin, Isabella Sperduti, +13 authors, Emilio Bria.
J Exp Clin Cancer Res, 2016 Mar 24; 35. PMID: 27000271    Free PMC article.
Equivalence of MammaPrint array types in clinical trials and diagnostics.
Inès Beumer, Anke Witteveen, +11 authors, Annuska Glas.
Breast Cancer Res Treat, 2016 Mar 24; 156(2). PMID: 27002507    Free PMC article.
Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial.
Karin Ribi, Weixiu Luo, +24 authors, Gini F Fleming.
J Clin Oncol, 2016 Mar 30; 34(14). PMID: 27022111    Free PMC article.
Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: TEXT and SOFT Trials.
Meredith M Regan, Prudence A Francis, +12 authors, Richard D Gelber.
J Clin Oncol, 2016 Apr 06; 34(19). PMID: 27044936    Free PMC article.
Progesterone receptor loss identifies hormone receptor-positive and HER2-negative breast cancer subgroups at higher risk of relapse: a retrospective cohort study.
Jia-Yuan Sun, San-Gang Wu, +2 authors, Zhen-Yu He.
Onco Targets Ther, 2016 Apr 07; 9. PMID: 27051305    Free PMC article.
Adjuvant endocrine therapy in premenopausal women with breast cancer.
Kunal C Kadakia, N Lynn Henry.
Clin Adv Hematol Oncol, 2016 Apr 09; 13(10). PMID: 27058571    Free PMC article.
CD74 and intratumoral immune response in breast cancer.
Zhi-Qiang Wang, Katy Milne, John R Webb, Peter H Watson.
Oncotarget, 2016 Apr 09; 8(8). PMID: 27058619    Free PMC article.
Impact of Oncotype DX Recurrence Score on Treatment Decisions: Results of a Prospective Multicenter Study in Turkey.
Vahit Ozmen, Ajlan Atasoy, +7 authors, Pinar Saip.
Cureus, 2016 Apr 16; 8(3). PMID: 27081583    Free PMC article.
Adjuvant ovarian function suppression and cognitive function in women with breast cancer.
Kelly-Anne Phillips, Meredith M Regan, +19 authors, Jürg Bernhard.
Br J Cancer, 2016 Apr 20; 114(9). PMID: 27092785    Free PMC article.
Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up.
Sara Bustreo, Simona Osella-Abate, +6 authors, Isabella Castellano.
Breast Cancer Res Treat, 2016 May 09; 157(2). PMID: 27155668    Free PMC article.
The prognostic role of RANK SNP rs34945627 in breast cancer patients with bone metastases.
Arlindo Ferreira, Irina Alho, +12 authors, Sandra Casimiro.
Oncotarget, 2016 May 19; 7(27). PMID: 27191503    Free PMC article.
A Decision Aid for Women Considering Neoadjuvant Systemic Therapy for Operable Invasive Breast Cancer: Development and Protocol of a Phase II Evaluation Study (ANZ1301 DOMINO).
Nicholas Zdenkowski, Phyllis Butow, +3 authors, Frances M Boyle.
JMIR Res Protoc, 2016 May 22; 5(2). PMID: 27207563    Free PMC article.
Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis.
Claire T Deakin, Shireena A Yasin, +11 authors, UK Juvenile Dermatomyositis Research Group.
Arthritis Rheumatol, 2016 Oct 28; 68(11). PMID: 27214289    Free PMC article.
Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence.
Jacquie H Chirgwin, Anita Giobbie-Hurder, +12 authors, Beat Thürlimann.
J Clin Oncol, 2016 May 25; 34(21). PMID: 27217455    Free PMC article.
Highly Cited.
Prognostic and Clinicopathological Value of Programmed Death Ligand-1 in Breast Cancer: A Meta-Analysis.
Yawen Guo, Pan Yu, +5 authors, Tao Huang.
PLoS One, 2016 May 27; 11(5). PMID: 27227453    Free PMC article.
Evaluating the Survival Benefit Following Ovarian Function Suppression in Premenopausal Patients with Hormone Receptor Positive Early Breast Cancer.
Lin Qiu, Fangmeng Fu, +4 authors, Chuan Wang.
Sci Rep, 2016 May 28; 6. PMID: 27230285    Free PMC article.
Review.
Does Breast Magnetic Resonance Imaging Combined With Conventional Imaging Modalities Decrease the Rates of Surgical Margin Involvement and Reoperation?: A Case-Control Comparative Analysis.
Hung-Wen Lai, Chih-Jung Chen, +6 authors, Dar-Ren Chen.
Medicine (Baltimore), 2016 Jun 04; 95(22). PMID: 27258520    Free PMC article.
Prognostic and predictive impacts of tumor-infiltrating lymphocytes differ between Triple-negative and HER2-positive breast cancers treated with standard systemic therapies.
Akira I Hida, Yasuaki Sagara, +8 authors, Yasuyo Ohi.
Breast Cancer Res Treat, 2016 Jun 05; 158(1). PMID: 27260189    Free PMC article.
Optimising Breast Conservation Treatment for Multifocal and Multicentric Breast Cancer: A Worthwhile Endeavour?: Reply.
Mona P Tan, Nadya Y Sitoh, Yih Y Sitoh.
World J Surg, 2016 Jun 09; 41(1). PMID: 27272268
Triple-negative breast cancer: treatment challenges and solutions.
Joëlle Collignon, Laurence Lousberg, Hélène Schroeder, Guy Jerusalem.
Breast Cancer (Dove Med Press), 2016 Jun 11; 8. PMID: 27284266    Free PMC article.
Highly Cited.
Breast Cancer-Specific Mortality Pattern and Its Changing Feature According to Estrogen Receptor Status in Two Time Periods.
Junjie Li, Yirong Liu, Yizhou Jiang, Zhimin Shao.
PLoS One, 2016 Jun 15; 11(6). PMID: 27299729    Free PMC article.
Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts.
Priyanka Sharma, Sara López-Tarruella, +31 authors, Miguel Martin.
Clin Cancer Res, 2016 Jun 16; 23(3). PMID: 27301700    Free PMC article.
Evaluation of the prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers.
Tian Tian, Miao Ruan, Wentao Yang, Ruohong Shui.
Oncotarget, 2016 Jun 22; 7(28). PMID: 27323808    Free PMC article.
Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00.
Marco Colleoni, Kathryn P Gray, +19 authors, Aron Goldhirsch.
J Clin Oncol, 2016 Jun 22; 34(28). PMID: 27325862    Free PMC article.
Biology and Management of Patients With Triple-Negative Breast Cancer.
Priyanka Sharma.
Oncologist, 2016 Jul 13; 21(9). PMID: 27401886    Free PMC article.
Review.
Value of Ki-67 expression in triple-negative breast cancer before and after neoadjuvant chemotherapy with weekly paclitaxel plus carboplatin.
Ruo-Xi Wang, Sheng Chen, Xi Jin, Zhi-Ming Shao.
Sci Rep, 2016 Jul 19; 6. PMID: 27426056    Free PMC article.
Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes.
Sasagu Kurozumi, Yuri Yamaguchi, +3 authors, Jun Horiguchi.
J Hum Genet, 2016 Jul 22; 62(1). PMID: 27439682
Review.
Influence of delayed initiation of adjuvant chemotherapy on breast cancer survival is subtype-dependent.
Ke-Da Yu, Lei Fan, +3 authors, Zhi-Ming Shao.
Oncotarget, 2016 Jul 23; 8(28). PMID: 27447963    Free PMC article.
HER2/CEP17 Ratios and Clinical Outcome in HER2-Positive Early Breast Cancer Undergoing Trastuzumab-Containing Therapy.
Albina Stocker, Marie-Luise Hilbers, +5 authors, Andreas Trojan.
PLoS One, 2016 Jul 28; 11(7). PMID: 27463363    Free PMC article.
Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway.
Daniela Massihnia, Antonio Galvano, +9 authors, Antonio Russo.
Oncotarget, 2016 Jul 31; 7(37). PMID: 27474173    Free PMC article.
Review.
Towards tumor immunodiagnostics.
Helen Kourea, Vassiliki Kotoula.
Ann Transl Med, 2016 Aug 27; 4(14). PMID: 27563650    Free PMC article.
Review.
A Nomogram for Predicting the Pathological Response of Axillary Lymph Node Metastasis in Breast Cancer Patients.
Xi Jin, Yi-Zhou Jiang, +2 authors, Gen-Hong Di.
Sci Rep, 2016 Sep 01; 6. PMID: 27576704    Free PMC article.
Sorafenib in breast cancer treatment: A systematic review and overview of clinical trials.
Menelaos Zafrakas, Panayiota Papasozomenou, Christos Emmanouilides.
World J Clin Oncol, 2016 Sep 01; 7(4). PMID: 27579253    Free PMC article.
ABCB1 and ABCC11 confer resistance to eribulin in breast cancer cell lines.
Takaaki Oba, Hiroto Izumi, Ken-Ichi Ito.
Oncotarget, 2016 Sep 03; 7(43). PMID: 27588398    Free PMC article.
Molecular subtypes and imaging phenotypes of breast cancer.
Nariya Cho.
Ultrasonography, 2016 Sep 08; 35(4). PMID: 27599892    Free PMC article.
Review.
Current Status of Long Non-Coding RNAs in Human Breast Cancer.
Stefanie Cerk, Daniela Schwarzenbacher, +6 authors, Martin Pichler.
Int J Mol Sci, 2016 Sep 09; 17(9). PMID: 27608009    Free PMC article.
Review.
DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer.
Nnennaya Kanu, Maria Antonietta Cerone, +14 authors, Charles Swanton.
Genome Biol, 2016 Sep 17; 17(1). PMID: 27634334    Free PMC article.
Highly Cited.
Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study.
André Hennigs, Fabian Riedel, +13 authors, Andreas Schneeweiss.
BMC Cancer, 2016 Sep 17; 16(1). PMID: 27634735    Free PMC article.
The combined endocrine receptor in breast cancer, a novel approach to traditional hormone receptor interpretation and a better discriminator of outcome than ER and PR alone.
Esther J Campbell, Mathias Tesson, +3 authors, Joanne Edwards.
Br J Cancer, 2016 Sep 23; 115(8). PMID: 27657341    Free PMC article.
The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis.
Bajin Wei, Minya Yao, +5 authors, Peifen Fu.
Onco Targets Ther, 2016 Sep 24; 9. PMID: 27660475    Free PMC article.
Highly Cited. Review.
Lymph Node Surgery - Stepwise Retirement for the Breast Surgeon?
Julia Landin, Walter P Weber.
Breast Care (Basel), 2016 Oct 11; 11(4). PMID: 27721717    Free PMC article.
Axillary and internal mammary sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy.
Xiao-Shan Cao, Hui-Juan Li, +5 authors, Yong-Sheng Wang.
Oncotarget, 2016 Oct 16; 7(45). PMID: 27738336    Free PMC article.
Incorporating Risk Factors to Identify the Indication of Post-mastectomy Radiotherapy in N1 Breast Cancer Treated with Optimal Systemic Therapy: A Multicenter Analysis in Korea (KROG 14-23).
Hae Jin Park, Kyung Hwan Shin, +12 authors, Suzy Kim.
Cancer Res Treat, 2016 Oct 22; 49(3). PMID: 27764904    Free PMC article.
Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping.
Pat Whitworth, Peter Beitsch, +10 authors, Jennifer Beatty.
Ann Surg Oncol, 2016 Oct 23; 24(3). PMID: 27770345    Free PMC article.
Optimal radiation dose for patients with one to three lymph node positive breast cancer following breast-conserving surgery and anthracycline plus taxane-based chemotherapy: A retrospective multicenter analysis (KROG 1418).
Haeyoung Kim, Won Park, +18 authors, Jong-Young Lee.
Oncotarget, 2016 Oct 30; 8(1). PMID: 27793036    Free PMC article.
Body Mass Index with Tumor 18F-FDG Uptake Improves Risk Stratification in Patients with Breast Cancer.
Seung Hyup Hyun, Hee Kyung Ahn, +7 authors, Kyung-Han Lee.
PLoS One, 2016 Nov 01; 11(10). PMID: 27798667    Free PMC article.
The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients.
Matteo Lambertini, Ana Catarina Pinto, +12 authors, Hatem A Azim.
Br J Cancer, 2016 Nov 02; 115(12). PMID: 27802449    Free PMC article.
ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer.
Kristina Magnusson, Gabriela Gremel, +5 authors, Fredrik Pontén.
BMC Cancer, 2016 Nov 20; 16(1). PMID: 27863473    Free PMC article.
Adjuvant chemotherapy and HER-2-directed therapy for early-stage breast cancer in the elderly.
J Sun, S Chia.
Br J Cancer, 2016 Nov 23; 116(1). PMID: 27875517    Free PMC article.
Review.
Bridging the gap between clinicians and systems biologists: from network biology to translational biomedical research.
Natini Jinawath, Sacarin Bunbanjerdsuk, +4 authors, Varodom Charoensawan.
J Transl Med, 2016 Nov 24; 14(1). PMID: 27876057    Free PMC article.
Review.
CD44 induces FOXP3 expression and is related with favorable outcome in breast carcinoma.
Elena Sanmartín, Fernando Ortiz-Martínez, +9 authors, Gloria Peiró.
Virchows Arch, 2016 Nov 26; 470(1). PMID: 27885422
Hormonal Modulation of Breast Cancer Gene Expression: Implications for Intrinsic Subtyping in Premenopausal Women.
Sarah M Bernhardt, Pallave Dasari, +3 authors, Wendy V Ingman.
Front Oncol, 2016 Nov 30; 6. PMID: 27896218    Free PMC article.
Review.
A METHYLATION-TO-EXPRESSION FEATURE MODEL FOR GENERATING ACCURATE PROGNOSTIC RISK SCORES AND IDENTIFYING DISEASE TARGETS IN CLEAR CELL KIDNEY CANCER.
Jeffrey A Thompson, Carmen J Marsit.
Pac Symp Biocomput, 2016 Nov 30; 22. PMID: 27897002    Free PMC article.
Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers.
Mattias Rantalainen, Daniel Klevebring, +10 authors, Henrik Grönberg.
Sci Rep, 2016 Dec 03; 6. PMID: 27901097    Free PMC article.
Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors.
Elina Uusitalo, Roope A Kallionpää, +9 authors, Juha Peltonen.
Br J Cancer, 2016 Dec 09; 116(2). PMID: 27931045    Free PMC article.
The Efficacy of Intraoperative Frozen Section Analysis During Breast-Conserving Surgery for Patients with Ductal Carcinoma In Situ.
Mi Jin Kim, Cheol Seung Kim, +2 authors, Kyu Dam Han.
Breast Cancer (Auckl), 2016 Dec 17; 10. PMID: 27980416    Free PMC article.
Cytochrome P-450 2D6 (CYP2D6) Genotype and Breast Cancer Recurrence in Tamoxifen-Treated Patients: Evaluating the Importance of Loss of Heterozygosity.
Thomas P Ahern, Daniel L Hertz, +7 authors, Deirdre P Cronin-Fenton.
Am J Epidemiol, 2016 Dec 19; 185(2). PMID: 27988492    Free PMC article.
Review.
Elevated YKL-40 expression is associated with a poor prognosis in breast cancer patients.
Guoxing Wan, Longchao Xiang, +4 authors, Fengjun Cao.
Oncotarget, 2016 Dec 31; 8(3). PMID: 28036271    Free PMC article.
MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
Zhishuang Li, Qingyong Meng, +4 authors, Li Li.
Oncotarget, 2016 Dec 31; 8(12). PMID: 28038450    Free PMC article.
Prognostic Impact of Elective Supraclavicular Nodal Irradiation for Patients with N1 Breast Cancer after Lumpectomy and Anthracycline Plus Taxane-Based Chemotherapy (KROG 1418): A Multicenter Case-Controlled Study.
Haeyoung Kim, Won Park, +19 authors, Jihye Cha.
Cancer Res Treat, 2017 Jan 06; 49(4). PMID: 28052649    Free PMC article.
Prognostic significance of Ki67 in Chinese women diagnosed with ER+/HER2- breast cancers by the 2015 St. Gallen consensus classification.
Yue Hu, Ran Gu, +9 authors, Weijuan Jia.
BMC Cancer, 2017 Jan 08; 17(1). PMID: 28061893    Free PMC article.
Fewer Reoperations After Lumpectomy for Breast Cancer with Neoadjuvant Rather than Adjuvant Chemotherapy: A Report from the National Cancer Database.
Jeffrey Landercasper, Barbara Bennie, +4 authors, Jared H Linebarger.
Ann Surg Oncol, 2017 Jan 08; 24(6). PMID: 28062931    Free PMC article.
Algorithms for prediction of the Oncotype DX recurrence score using clinicopathologic data: a review and comparison using an independent dataset.
Michael R Harowicz, Timothy J Robinson, +4 authors, Maciej A Mazurowski.
Breast Cancer Res Treat, 2017 Jan 09; 162(1). PMID: 28064383    Free PMC article.
Imaging Surveillance After Primary Breast Cancer Treatment.
Diana L Lam, Nehmat Houssami, Janie M Lee.
AJR Am J Roentgenol, 2017 Jan 12; 208(3). PMID: 28075622    Free PMC article.
Review.
Discordance Rate in Estrogen Receptor, Progesterone Receptor, HER2 Status, and Ki67 Index Between Primary Unifocal and Multiple Homogenous Breast Carcinomas and Synchronous Axillary Lymph Node Metastases Have an Impact on Therapeutic Decision.
Rares Georgescu, Monica Boros, +6 authors, Simona Stolnicu.
Appl Immunohistochem Mol Morphol, 2017 Jan 19; 26(8). PMID: 28099174    Free PMC article.
Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: results of an observational study.
Claudia Bighin, Beatrice Dozin, +12 authors, Lucia Del Mastro.
Oncotarget, 2017 Jan 22; 8(27). PMID: 28108743    Free PMC article.
Ki-67 as a prognostic marker according to breast cancer molecular subtype.
Nahed A Soliman, Shaimaa M Yussif.
Cancer Biol Med, 2017 Feb 06; 13(4). PMID: 28154782    Free PMC article.
Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Results of a Prospective, Noninterventional Study on Routine Treatment Between 2006 and 2012 in Germany.
Peter Dall, Thorsten Koch, +11 authors, Gabriele Feisel-Schwickardi.
Oncologist, 2017 Feb 09; 22(2). PMID: 28174294    Free PMC article.
Non-anthracycline-containing docetaxel and cyclophosphamide regimen is associated with sustained worse outcome compared with docetaxel, anthracycline and cyclophosphamide in neoadjuvant treatment of triple negative and HER2-positive breast cancer patients: updated follow-up data from NATT study.
Xiaosong Chen, Guolin Ye, +2 authors, Kunwei Shen.
Chin J Cancer Res, 2017 Feb 09; 28(6). PMID: 28174484    Free PMC article.
Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer?
Michael R Harowicz, Ashirbani Saha, +4 authors, Maciej A Mazurowski.
J Magn Reson Imaging, 2017 Feb 10; 46(5). PMID: 28181348    Free PMC article.
Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer.
Matteo Lambertini, Lucia Del Mastro, +3 authors, Evandro de Azambuja.
Curr Treat Options Oncol, 2017 Feb 12; 18(1). PMID: 28185173
Review.
A comparison of Ki-67 counting methods in luminal Breast Cancer: The Average Method vs. the Hot Spot Method.
Min Hye Jang, Hyun Jung Kim, +2 authors, So Yeon Park.
PLoS One, 2017 Feb 12; 12(2). PMID: 28187177    Free PMC article.
Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer.
Hans-Peter Sinn, Andreas Schneeweiss, +9 authors, Frederik Marmé.
BMC Cancer, 2017 Feb 15; 17(1). PMID: 28193205    Free PMC article.
Bone metastasis risk factors in breast cancer.
Catarina Pulido, Inês Vendrell, +4 authors, Luís Costa.
Ecancermedicalscience, 2017 Feb 15; 11. PMID: 28194227    Free PMC article.
Review.
Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancer.
Sura Aziz, Elisabeth Wik, +6 authors, Lars A Akslen.
PLoS One, 2017 Feb 16; 12(2). PMID: 28199370    Free PMC article.
Pathway Oriented Therapy in Breast Cancer - a Light at the End of the Tunnel!
Eugen Ruckhäberle, Tanja Fehm.
Breast Care (Basel), 2017 Feb 24; 11(6). PMID: 28228703    Free PMC article.
High Residual Tumor Rate for Early Breast Cancer Patients Receiving Vacuum-assisted Breast Biopsy.
Xiao-Fang He, Feng Ye, +4 authors, Xiao-Ming Xie.
J Cancer, 2017 Mar 07; 8(3). PMID: 28261351    Free PMC article.
Risk factors for delay of adjuvant chemotherapy in non-metastatic breast cancer patients: A systematic review and meta-analysis involving 186982 patients.
Xiaofang He, Fen Ye, +4 authors, Xiaoming Xie.
PLoS One, 2017 Mar 17; 12(3). PMID: 28301555    Free PMC article.
Systematic Review.
Restricted Axillary Staging in Clinically and Sonographically Node-Negative Early Invasive Breast Cancer (c/iT1-2) in the Context of Breast Conserving Therapy: First Results Following Commencement of the Intergroup-Sentinel-Mamma (INSEMA) Trial.
T Reimer, A Stachs, +5 authors, B Gerber.
Geburtshilfe Frauenheilkd, 2017 Mar 24; 77(2). PMID: 28331237    Free PMC article.
Correlations Between Oncotype DX Recurrence Score and Classic Risk Factors in Early Breast Cancer: Results of A Prospective Multicenter Study in Turkey.
Vahit Özmen, Ajlan Atasoy, +9 authors, Pınar Saip.
J Breast Health, 2016 Jan 01; 12(3). PMID: 28331745    Free PMC article.
A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2- early breast cancer.
Gyungyub Gong, Mi Jeong Kwon, +15 authors, Young Kee Shin.
Sci Rep, 2017 Mar 30; 7. PMID: 28350001    Free PMC article.
Preexposure of MCF-7 breast cancer cell line to dexamethasone alters the cytotoxic effect of paclitaxel but not 5-fluorouracil or epirubicin chemotherapy.
Frederic Buxant, Nadège Kindt, +2 authors, Sven Saussez.
Breast Cancer (Dove Med Press), 2017 Mar 30; 9. PMID: 28352202    Free PMC article.
Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors.
Wilfred Truin, Rudi M H Roumen, +3 authors, Adri C Voogd.
Breast Cancer Res Treat, 2017 Apr 04; 164(1). PMID: 28365833    Free PMC article.
Prognostic Influence of BCL2 on Molecular Subtypes of Breast Cancer.
Ki-Tae Hwang, Wonshik Han, +6 authors, Dong-Young Noh.
J Breast Cancer, 2017 Apr 07; 20(1). PMID: 28382095    Free PMC article.
Breast cancer in Iraq is associated with a unimodally distributed predominance of luminal type B over luminal type A surrogates from young to old age.
Runnak A Majid, Hemin A Hassan, +2 authors, Michael D Hughson.
BMC Womens Health, 2017 Apr 09; 17(1). PMID: 28388952    Free PMC article.
Reproducibility and Prognostic Potential of Ki-67 Proliferation Index when Comparing Digital-Image Analysis with Standard Semi-Quantitative Evaluation in Breast Cancer.
Balázs Ács, Lilla Madaras, +5 authors, Attila Marcell Szász.
Pathol Oncol Res, 2017 Apr 13; 24(1). PMID: 28401450
Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10).
Bernhard C Pestalozzi, Christoph Tausch, +17 authors, Swiss Group for Clinical Cancer Research (SAKK).
BMC Cancer, 2017 Apr 15; 17(1). PMID: 28407750    Free PMC article.
MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer.
Jinil Han, Yoon-La Choi, +11 authors, Young Kee Shin.
Breast Cancer Res Treat, 2017 Apr 15; 164(1). PMID: 28409241    Free PMC article.
Clinicopathologic study of invasive micropapillary carcinoma of the breast.
Shen-Li Tang, Ji-Qiao Yang, +4 authors, Qing Lv.
Oncotarget, 2017 Apr 19; 8(26). PMID: 28418916    Free PMC article.
No Association of Positive Superficial and/or Deep Margins with Local Recurrence in Invasive Breast Cancer Treated with Breast-Conserving Surgery.
Tae In Yoon, Jong Won Lee, +12 authors, Sei Hyun Ahn.
Cancer Res Treat, 2017 Apr 20; 50(1). PMID: 28421725    Free PMC article.
Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer.
Aranzazu Fernandez-Martinez, Tomás Pascual, +30 authors, Miguel Martin.
Oncotarget, 2017 Apr 21; 8(13). PMID: 28423537    Free PMC article.
Role of postmastectomy radiotherapy in early-stage (T1-2N0-1M0) triple-negative breast cancer: a systematic review.
Fengxia Chen, Feifei Pu.
Onco Targets Ther, 2017 Apr 25; 10. PMID: 28435291    Free PMC article.
Review.
Adjuvant Endocrine Therapy in Breast Cancer: Evolving Paradigms in Premenopausal Women.
Lorenzo Rossi, Olivia Pagani.
Curr Treat Options Oncol, 2017 Apr 26; 18(5). PMID: 28439796
Review.
A breast cancer gene signature for indolent disease.
Leonie J M J Delahaye, Caroline A Drukker, +8 authors, Annuska M Glas.
Breast Cancer Res Treat, 2017 Apr 30; 164(2). PMID: 28451965    Free PMC article.
Stemness in Cancer: Stem Cells, Cancer Stem Cells, and Their Microenvironment.
Pedro M Aponte, Andrés Caicedo.
Stem Cells Int, 2017 May 06; 2017. PMID: 28473858    Free PMC article.
Highly Cited. Review.
The Noninvasive Treatment for Sentinel Lymph Node Metastasis by Photodynamic Therapy Using Phospholipid Polymer as a Nanotransporter of Verteporfin.
Kyosuke Shimada, Sachiko Matsuda, +5 authors, Yuko Kitagawa.
Biomed Res Int, 2017 May 06; 2017. PMID: 28473989    Free PMC article.
Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections.
Abir A Muftah, Mohammed A Aleskandarany, +7 authors, Andrew R Green.
Breast Cancer Res Treat, 2017 May 10; 164(2). PMID: 28478613    Free PMC article.
Clinicopathological and Molecular Study of Triple-Negative Breast Cancer in Algerian Patients.
Hadjer Gaceb, Farid Cherbal, +2 authors, Hassen Mahfouf.
Pathol Oncol Res, 2017 May 10; 24(2). PMID: 28478614
Correlations between Tumor to Background Ratio on Breast-Specific Gamma Imaging and Prognostic Factors in Breast Cancer.
Soo Jin Lee, Yun Young Choi, Chanwoo Kim, Min Sung Chung.
J Korean Med Sci, 2017 May 10; 32(6). PMID: 28480663    Free PMC article.
Quality assurance trials for Ki67 assessment in pathology.
M Raap, S Ließem, +5 authors, H Kreipe.
Virchows Arch, 2017 May 13; 471(4). PMID: 28497316
Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index.
Sasagu Kurozumi, Hiroshi Matsumoto, +6 authors, Masafumi Kurosumi.
BMC Cancer, 2017 May 24; 17(1). PMID: 28532429    Free PMC article.
The 21-gene recurrence score in special histologic subtypes of breast cancer with favorable prognosis.
Gulisa Turashvili, Edi Brogi, +4 authors, Hannah Y Wen.
Breast Cancer Res Treat, 2017 Jun 04; 165(1). PMID: 28577081    Free PMC article.
Molecular characterization of breast cancer cell lines by clinical immunohistochemical markers.
André de Lima Mota, Adriane Feijo Evangelista, +4 authors, Marcia Maria Chiquitelli Marques.
Oncol Lett, 2017 Jun 08; 13(6). PMID: 28588725    Free PMC article.
Incorporating Tumor Characteristics to the American Joint Committee on Cancer Breast Cancer Staging System.
Mariana Chavez-MacGregor, Elizabeth A Mittendorf, +3 authors, Sharon H Giordano.
Oncologist, 2017 Jun 09; 22(11). PMID: 28592619    Free PMC article.
Expression of regulatory factor X1 can predict the prognosis of breast cancer.
Masahiro Shibata, Mitsuro Kanda, +12 authors, Toyone Kikumori.
Oncol Lett, 2017 Jun 11; 13(6). PMID: 28599435    Free PMC article.
Does the 1H-NMR plasma metabolome reflect the host-tumor interactions in human breast cancer?
Vincent Richard, Raphaël Conotte, David Mayne, Jean-Marie Colet.
Oncotarget, 2017 Jun 15; 8(30). PMID: 28611296    Free PMC article.
Neoadjuvant Therapy for Breast Cancer: Established Concepts and Emerging Strategies.
Tessa G Steenbruggen, Mette S van Ramshorst, +3 authors, Gabe S Sonke.
Drugs, 2017 Jun 16; 77(12). PMID: 28616845
Review.
Precision medicine in breast cancer: reality or utopia?
Ali Bettaieb, Catherine Paul, +3 authors, François Ghiringhelli.
J Transl Med, 2017 Jun 19; 15(1). PMID: 28623955    Free PMC article.
Review.
Current advances in endocrine therapy options for premenopausal women with hormone receptor positive breast cancer.
Mary L Gemignani, David J Hetzel.
Gynecol Oncol, 2017 Jul 01; 147(1). PMID: 28662774    Free PMC article.
Review.
Does adjuvant chemotherapy change bone mineral density and related serum biomarkers in women with breast cancer?
Reza Safaei-Nodehi, Javad Esmaili, +2 authors, Sayeh Parkhideh.
Caspian J Intern Med, 2017 Jul 14; 8(2). PMID: 28702147    Free PMC article.
FOXP3 Allelic Variants and Haplotype Structures Are Associated with Aggressive Breast Cancer Subtypes.
Bruna Karina Banin Hirata, Roberta Losi Guembarovski, +3 authors, Maria Angelica Ehara Watanabe.
Dis Markers, 2017 Jul 18; 2017. PMID: 28713192    Free PMC article.
Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration.
Samuel C Y Leung, Torsten O Nielsen, +31 authors, Mitch Dowsett.
NPJ Breast Cancer, 2016 May 18; 2. PMID: 28721378    Free PMC article.
Bioscore: A Staging System for Breast Cancer Patients that Reflects the Prognostic Significance of Underlying Tumor Biology.
Elizabeth A Mittendorf, Mariana Chavez-MacGregor, +5 authors, Kelly K Hunt.
Ann Surg Oncol, 2017 Jul 21; 24(12). PMID: 28726077    Free PMC article.
Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib.
Hampig Raphael Kourie, Elie El Rassy, +2 authors, Matteo Lambertini.
Onco Targets Ther, 2017 Jul 27; 10. PMID: 28744140    Free PMC article.
Review.
E-cadherin expression phenotypes associated with molecular subtypes in invasive non-lobular breast cancer: evidence from a retrospective study and meta-analysis.
Jiang-Bo Liu, Chen-Yi Feng, +4 authors, Xiao-Shan Feng.
World J Surg Oncol, 2017 Aug 03; 15(1). PMID: 28764784    Free PMC article.
MicroRNA-519a-3p mediates apoptosis resistance in breast cancer cells and their escape from recognition by natural killer cells.
Christian Breunig, Jens Pahl, +8 authors, Stefan Wiemann.
Cell Death Dis, 2017 Aug 05; 8(8). PMID: 28771222    Free PMC article.
Identifying Biomarkers to Select Patients with Early Breast Cancer Suitable for Extended Adjuvant Endocrine Therapy.
Ivana Sestak.
Breast Care (Basel), 2017 Aug 09; 12(3). PMID: 28785181    Free PMC article.
Review.
Disparities of Trastuzumab Use in Resource-Limited or Resource-Abundant Regions and Its Survival Benefit on HER2 Positive Breast Cancer: A Real-World Study from China.
Jianbin Li, Shusen Wang, +11 authors, Zefei Jiang.
Oncologist, 2017 Aug 12; 22(11). PMID: 28798274    Free PMC article.
Feasibility of Preoperative Axillary Lymph Node Marking with a Clip in Breast Cancer Patients Before Neoadjuvant Chemotherapy: A Preliminary Study.
Eun Young Kim, Woo Seok Byon, +8 authors, Sung-Im Do.
World J Surg, 2017 Aug 16; 42(2). PMID: 28808843
Prognostic value of routine laboratory variables in prediction of breast cancer recurrence.
Zhu Zhu, Ling Li, +8 authors, Zhimin Fan.
Sci Rep, 2017 Aug 16; 7(1). PMID: 28811593    Free PMC article.
Separase is a marker for prognosis and mitotic activity in breast cancer.
Natalia Gurvits, Eliisa Löyttyniemi, +3 authors, Kati Talvinen.
Br J Cancer, 2017 Sep 01; 117(9). PMID: 28859055    Free PMC article.
Decision impact and feasibility of different ASCO-recommended biomarkers in early breast cancer: Prospective comparison of molecular marker EndoPredict and protein marker uPA/PAI-1.
Johannes Ettl, Evelyn Klein, +7 authors, Marion Kiechle.
PLoS One, 2017 Sep 07; 12(9). PMID: 28877230    Free PMC article.
Predictive and prognostic impact of tumour-infiltrating lymphocytes in triple-negative breast cancer treated with neoadjuvant chemotherapy.
Carmen Herrero-Vicent, Angel Guerrero, +7 authors, Amparo Ruiz-Simón.
Ecancermedicalscience, 2017 Sep 14; 11. PMID: 28900472    Free PMC article.
Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry.
Salomon M Stemmer, Mariana Steiner, +13 authors, Noa Ben-Baruch.
NPJ Breast Cancer, 2017 Sep 14; 3. PMID: 28900632    Free PMC article.
Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry.
Salomon M Stemmer, Mariana Steiner, +21 authors, Nicky Liebermann.
NPJ Breast Cancer, 2017 Sep 14; 3. PMID: 28900633    Free PMC article.
The Impact of Young Age for Prognosis by Subtype in Women with Early Breast Cancer.
Weibin Lian, Fangmeng Fu, +6 authors, Chuan Wang.
Sci Rep, 2017 Sep 16; 7(1). PMID: 28912475    Free PMC article.
Clinical Impact of Sphingosine-1-Phosphate in Breast Cancer.
Junko Tsuchida, Masayuki Nagahashi, Kazuaki Takabe, Toshifumi Wakai.
Mediators Inflamm, 2017 Sep 16; 2017. PMID: 28912626    Free PMC article.
Review.
Therapeutic Implications of the Molecular and Immune Landscape of Triple-Negative Breast Cancer.
Ana C Gregório, Manuela Lacerda, +3 authors, João Nuno Moreira.
Pathol Oncol Res, 2017 Sep 16; 24(4). PMID: 28913723
Review.
Androgen receptor expression identifies patient with favorable outcome in operable triple negative breast cancer.
Xiao-Qing Hu, Wei-Li Chen, Hai-Guang Ma, Ke Jiang.
Oncotarget, 2017 Sep 17; 8(34). PMID: 28915596    Free PMC article.
Assessment of Ki67 and uPA/PAI-1 expression in intermediate-risk early stage breast cancers.
Elise Deluche, Laurence Venat-Bouvet, +6 authors, Nicole Tubiana-Mathieu.
BMC Cancer, 2017 Sep 29; 17(1). PMID: 28954632    Free PMC article.
Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancer.
T Fujii, T Kogawa, +10 authors, N T Ueno.
Ann Oncol, 2017 Sep 30; 28(10). PMID: 28961844    Free PMC article.
Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer Cohorts.
Arian Lundberg, Linda S Lindström, +8 authors, Nicholas P Tobin.
Clin Cancer Res, 2017 Oct 04; 23(24). PMID: 28972043    Free PMC article.
Clinically relevant morphological structures in breast cancer represent transcriptionally distinct tumor cell populations with varied degrees of epithelial-mesenchymal transition and CD44+CD24- stemness.
Evgeny V Denisov, Nikolay A Skryabin, +9 authors, Vladimir M Perelmuter.
Oncotarget, 2017 Oct 06; 8(37). PMID: 28977854    Free PMC article.
Prognostic immune-related gene models for breast cancer: a pooled analysis.
Jianli Zhao, Ying Wang, +6 authors, Kai Chen.
Onco Targets Ther, 2017 Oct 06; 10. PMID: 28979134    Free PMC article.
Endocrine sensitivity of estrogen receptor-positive breast cancer is negatively correlated with aspartate-β-hydroxylase expression.
Masafumi Shimoda, Ami Hori, +8 authors, Shinzaburo Noguchi.
Cancer Sci, 2017 Oct 07; 108(12). PMID: 28985022    Free PMC article.
Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online.
Beate Jahn, Ursula Rochau, +9 authors, Uwe Siebert.
BMC Cancer, 2017 Oct 19; 17(1). PMID: 29037213    Free PMC article.
ER-positive breast cancer patients with more than three positive nodes or grade 3 tumors are at high risk of late recurrence after 5-year adjuvant endocrine therapy.
Fangbin Song, Jianbing Zhang, +6 authors, Junming Xu.
Onco Targets Ther, 2017 Oct 19; 10. PMID: 29042797    Free PMC article.
Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna® Test in the management of early-stage breast cancers.
Delphine Hequet, Céline Callens, +20 authors, Roman Rouzier.
PLoS One, 2017 Oct 19; 12(10). PMID: 29045452    Free PMC article.
Computer-aided evaluation of the correlation between MRI morphology and immunohistochemical biomarkers or molecular subtypes in breast cancer.
Sen Jiang, You-Jia Hong, Fan Zhang, Yang-Kang Li.
Sci Rep, 2017 Oct 25; 7(1). PMID: 29062076    Free PMC article.
Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer.
Charles Johannessen, Line Moi, +4 authors, Lill-Tove Busund.
PLoS One, 2017 Oct 27; 12(10). PMID: 29073169    Free PMC article.
Gene Expression Profiling in Breast Cancer and Its Effect on Therapy Selection in Early-Stage Breast Cancer.
E Nilüfer Güler.
Eur J Breast Health, 2017 Oct 31; 13(4). PMID: 29082373    Free PMC article.
Review.
Assessing the Clinical Benefit of Systemic Adjuvant Therapies for Early Breast Cancer.
Volker Möbus, Susanne Hell, Marcus Schmidt.
Geburtshilfe Frauenheilkd, 2017 Nov 03; 77(10). PMID: 29093601    Free PMC article.
The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer.
Barbara Adamo, Giuseppina Rosaria Rita Ricciardi, +7 authors, Vincenzo Adamo.
Oncotarget, 2017 Nov 05; 8(44). PMID: 29100362    Free PMC article.
Predicting level 2 axillary lymph node metastasis in a Chinese breast cancer population post-neoadjuvant chemotherapy: development and assessment of a new predictive nomogram.
Caigang Liu, Yanlin Jiang, +11 authors, Qiyong Guo.
Oncotarget, 2017 Nov 08; 8(45). PMID: 29108294    Free PMC article.
Weekly paclitaxel and cisplatin as neoadjuvant chemotherapy with locally advanced breast cancer: a prospective, single arm, phase II study.
Liheng Zhou, Shuguang Xu, +7 authors, Jinsong Lu.
Oncotarget, 2017 Nov 08; 8(45). PMID: 29108309    Free PMC article.
Effect of denosumab administration on low bone mineral density (T-score -1.0 to -2.5) in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer.
Katsuhiko Nakatsukasa, Hiroshi Koyama, +6 authors, Tetsuya Taguchi.
J Bone Miner Metab, 2017 Nov 09; 36(6). PMID: 29116414
Clinicopathologic and prognostic features of breast cancer in young women: a series from North of Morocco.
Joaira Bakkach, Mohamed Mansouri, +6 authors, Mohcine Bennani Mechita.
BMC Womens Health, 2017 Nov 11; 17(1). PMID: 29121898    Free PMC article.
Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer.
Andrew Dodson, David Okonji, +6 authors, Mitch Dowsett.
Breast Cancer Res Treat, 2017 Nov 13; 168(1). PMID: 29128896    Free PMC article.
First Prospective Multicenter Italian Study on the Impact of the 21-Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer.
Maria Vittoria Dieci, Valentina Guarneri, +15 authors, PierFranco Conte.
Oncologist, 2017 Nov 15; 23(3). PMID: 29133514    Free PMC article.
Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.
Hege O Ohnstad, Elin Borgen, +11 authors, Bjørn Naume.
Breast Cancer Res, 2017 Nov 16; 19(1). PMID: 29137653    Free PMC article.
Evaluation of guidelines regarding surgical treatment of breast cancer using the AGREE Instrument: a systematic review.
Xin Lei, Fengtao Liu, +5 authors, Shunrong Li.
BMJ Open, 2017 Nov 16; 7(11). PMID: 29138191    Free PMC article.
Systematic Review.
Comparable Survival between Additional Radiotherapy and Local Surgery in Occult Breast Cancer after Axillary Lymph Node Dissection: A Population-based Analysis.
San-Gang Wu, Wen-Wen Zhang, +4 authors, Zhen-Yu He.
J Cancer, 2017 Nov 21; 8(18). PMID: 29151972    Free PMC article.
The role of BRCA status on prognosis in patients with triple-negative breast cancer.
Yuxin Xie, Qiheng Gou, +2 authors, Hong Zheng.
Oncotarget, 2017 Nov 21; 8(50). PMID: 29152070    Free PMC article.
Triptorelin: A Review of its Use as an Adjuvant Anticancer Therapy in Early Breast Cancer.
James E Frampton.
Drugs, 2017 Nov 28; 77(18). PMID: 29177573
Review.
Adjuvant chemotherapeutic treatment of 1650 patients with early breast cancer in routine care in Germany: data from the prospective TMK cohort study.
Steffen Dörfel, Claus-Christoph Steffens, +6 authors, TMK-Group (Tumour Registry Breast Cancer).
Breast Cancer, 2017 Dec 06; 25(3). PMID: 29204847    Free PMC article.
Breast cancer: The translation of big genomic data to cancer precision medicine.
Siew-Kee Low, Hitoshi Zembutsu, Yusuke Nakamura.
Cancer Sci, 2017 Dec 08; 109(3). PMID: 29215763    Free PMC article.
Review.
Validation Study of the American Joint Committee on Cancer Eighth Edition Prognostic Stage Compared With the Anatomic Stage in Breast Cancer.
Anna Weiss, Mariana Chavez-MacGregor, +6 authors, Elizabeth A Mittendorf.
JAMA Oncol, 2017 Dec 10; 4(2). PMID: 29222540    Free PMC article.
Ki-67 Expression by Immunohistochemistry and Quantitative Real-Time Polymerase Chain Reaction as Predictor of Clinical Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.
Prihantono Prihantono, Mochammad Hatta, +5 authors, Andi Nilawati Usman.
J Oncol, 2017 Dec 12; 2017. PMID: 29225623    Free PMC article.
Predictive value of vascular endothelial growth factor receptor type 2 in triple-negative breast cancer patients treated with neoadjuvant chemotherapy.
Nataliya Babyshkina, Marina Zavyalova, +6 authors, Nadejda Cherdyntseva.
Mol Cell Biochem, 2017 Dec 13; 444(1-2). PMID: 29230610
Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
R Colomer, I Aranda-López, +7 authors, J Palacios-Calvo.
Clin Transl Oncol, 2017 Dec 24; 20(7). PMID: 29273958    Free PMC article.
Review.
Instrumented Spinal Stabilization without Fusion for Spinal Metastatic Disease.
Dori Drakhshandeh, James A Miller, Andrew J Fabiano.
World Neurosurg, 2017 Dec 25; 111. PMID: 29275052    Free PMC article.
Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer.
Ming Li, Anqi Li, +4 authors, Wentao Yang.
BMC Cancer, 2018 Jan 03; 18(1). PMID: 29291717    Free PMC article.
The prognostic value of Ki67 in ovarian high-grade serous carcinoma: an 11-year cohort study of Chinese patients.
Ming Chen, Shuzhong Yao, +3 authors, Mian He.
Oncotarget, 2018 Jan 04; 8(64). PMID: 29296209    Free PMC article.
Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients.
Silvana Anna Maria Urru, Silvano Gallus, +25 authors, Sandra Orrù.
BMC Cancer, 2018 Jan 10; 18(1). PMID: 29310602    Free PMC article.
Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study.
Peter Dall, Thorsten Koch, +11 authors, Gabriele Feisel-Schwickardi.
BMC Cancer, 2018 Jan 10; 18(1). PMID: 29310623    Free PMC article.
Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative.
L Rydén, N Loman, +7 authors, Å Borg.
Br J Surg, 2018 Jan 18; 105(2). PMID: 29341157    Free PMC article.
Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysis.
Carmine De Angelis, Massimo Di Maio, +12 authors, Grazia Arpino.
Oncotarget, 2018 Jan 20; 8(68). PMID: 29348868    Free PMC article.
Prospective Evaluation of the Impact of the 21-Gene Recurrence Score Assay on Adjuvant Treatment Decisions for Women with Node-Positive Breast Cancer in Ontario, Canada.
Sofia Torres, Maureen Trudeau, +7 authors, Andrea Eisen.
Oncologist, 2018 Jan 27; 23(7). PMID: 29371476    Free PMC article.
Can Histological Grade and Mitotic Index Replace Ki67 to Determine Luminal Breast Cancer Subtypes?
David Oddó, Dahiana Pulgar, +11 authors, César Sánchez.
Asian Pac J Cancer Prev, 2018 Jan 28; 19(1). PMID: 29373911    Free PMC article.
Celecoxib targets breast cancer stem cells by inhibiting the synthesis of prostaglandin E2 and down-regulating the Wnt pathway activity.
Chaolin Huang, Yuanhong Chen, +8 authors, Qiaoxiang Dong.
Oncotarget, 2018 Feb 01; 8(70). PMID: 29383157    Free PMC article.
Pre-operative and intra-operative detection of axillary lymph node metastases in 108 patients with invasive lobular breast cancer undergoing mastectomy.
Jerica Novak, Nikola Besic, +2 authors, Andrej Vogrin.
BMC Cancer, 2018 Feb 07; 18(1). PMID: 29402252    Free PMC article.
A study of association of Oncotype DX recurrence score with DCE-MRI characteristics using multivariate machine learning models.
Ashirbani Saha, Michael R Harowicz, Weiyao Wang, Maciej A Mazurowski.
J Cancer Res Clin Oncol, 2018 Feb 11; 144(5). PMID: 29427210    Free PMC article.
Metabolic Footprints and Molecular Subtypes in Breast Cancer.
Vera Cappelletti, Egidio Iorio, +3 authors, Maria Grazia Daidone.
Dis Markers, 2018 Feb 13; 2017. PMID: 29434411    Free PMC article.
Review.
Significance of lung biopsy for the definitive diagnosis of lung nodules in breast cancer patients.
Kazuo Matsuura, Toshiyuki Itamoto, +7 authors, Morihito Okada.
Mol Clin Oncol, 2018 Feb 13; 8(2). PMID: 29435285    Free PMC article.
Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Ivana Sestak, Richard Buus, +9 authors, Mitch Dowsett.
JAMA Oncol, 2018 Feb 17; 4(4). PMID: 29450494    Free PMC article.
Highly Cited.
Preliminary Study of the Role F-Box Protein 32 (FBXO32) in Colorectal Neoplasms Through the Transforming Growth Factor beta (TGF-β)/Smad4 Signalling Pathway.
Xuemin Yuan, Zhen Zhang, +2 authors, Yanqing Li.
Med Sci Monit, 2018 Feb 22; 24. PMID: 29465067    Free PMC article.
A Metabolomic Approach to Predict Breast Cancer Behavior and Chemotherapy Response.
Marcella Regina Cardoso, Juliana Carvalho Santos, +3 authors, Sophie Françoise Mauricette Derchain.
Int J Mol Sci, 2018 Feb 22; 19(2). PMID: 29466297    Free PMC article.
Review.
Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy.
Paula Cabrera-Galeana, Wendy Muñoz-Montaño, +9 authors, Oscar Arrieta.
Oncologist, 2018 Mar 02; 23(6). PMID: 29490940    Free PMC article.
Prognostic & predictive factors for planning adjuvant chemotherapy of early-stage breast cancer.
Onur Esbah, Berna Oksuzoglu.
Indian J Med Res, 2018 Mar 08; 146(5). PMID: 29512598    Free PMC article.
Review.
Predictive markers for efficacy of everolimus plus exemestane in patients with luminal HER2-negative metastatic breast cancer.
Misato Okazaki, Yoshiya Horimoto, +5 authors, Mitsue Saito.
Med Oncol, 2018 Mar 10; 35(4). PMID: 29520681
Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial.
Takayuki Ueno, Shigehira Saji, +12 authors, Masakazu Toi.
ESMO Open, 2018 Mar 14; 3(2). PMID: 29531841    Free PMC article.
Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidences.
Fedro Alessandro Peccatori, Matteo Lambertini, +2 authors, Giovanni Codacci-Pisanelli.
Cancer Biol Med, 2018 Mar 17; 15(1). PMID: 29545964    Free PMC article.
Spotlight on triptorelin in the treatment of premenopausal women with early-stage breast cancer.
Marta Venturelli, Giorgia Guaitoli, Claudia Omarini, Luca Moscetti.
Breast Cancer (Dove Med Press), 2018 Mar 20; 10. PMID: 29551913    Free PMC article.
Review.
Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer.
Anna C Wilkins, Barry Gusterson, +9 authors, CHHiP Trial Investigators.
Int J Radiat Oncol Biol Phys, 2018 Mar 22; 101(2). PMID: 29559283    Free PMC article.
Breast cancer survival, survival disparities, and guideline-based treatment.
Deirdre A Hill, Sarah Friend, +4 authors, Melanie Royce.
Breast Cancer Res Treat, 2018 Mar 24; 170(2). PMID: 29569018    Free PMC article.
Methylation-to-Expression Feature Models of Breast Cancer Accurately Predict Overall Survival, Distant-Recurrence Free Survival, and Pathologic Complete Response in Multiple Cohorts.
Jeffrey A Thompson, Brock C Christensen, Carmen J Marsit.
Sci Rep, 2018 Mar 28; 8(1). PMID: 29581450    Free PMC article.
The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer.
Xin An, Fei Xu, +8 authors, Shusen Wang.
BMC Cancer, 2018 Mar 29; 18(1). PMID: 29587760    Free PMC article.
Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals.
Purificación Martínez Del Prado, Isabel Alvarez-López, +7 authors, Javier Mar.
Clinicoecon Outcomes Res, 2018 Mar 30; 10. PMID: 29593426    Free PMC article.
Update on the Treatment of Early-Stage Triple-Negative Breast Cancer.
Priyanka Sharma.
Curr Treat Options Oncol, 2018 Apr 16; 19(5). PMID: 29656345
Review.
Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance.
Gorka Ruiz de Garibay, Francesca Mateo, +19 authors, Miguel Angel Pujana.
Dis Model Mech, 2018 Apr 19; 11(5). PMID: 29666142    Free PMC article.
Management of the Axilla in the Era of Breast Cancer Heterogeneity.
Maïlys de Meric de Bellefon, Claire Lemanski, +3 authors, Celine Bourgier.
Front Oncol, 2018 Apr 20; 8. PMID: 29670853    Free PMC article.
Review.
Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor-Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5.
Mitch Dowsett, Ivana Sestak, +5 authors, Jack Cuzick.
J Clin Oncol, 2018 Apr 21; 36(19). PMID: 29676944    Free PMC article.
Effect of miR-146a-5p on proliferation and metastasis of triple-negative breast cancer via regulation of SOX5.
Chengshuai Si, Qiao Yu, Yufeng Yao.
Exp Ther Med, 2018 May 08; 15(5). PMID: 29731835    Free PMC article.
Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab.
James N Ingle, Krishna R Kalari, +16 authors, Richard M Weinshilboum.
Pharmacogenet Genomics, 2018 May 17; 28(6). PMID: 29768301    Free PMC article.
Survival benefit of neoadjuvant chemotherapy for resectable breast cancer: A meta-analysis.
Yan Chen, Xiu-E Shi, +3 authors, Ke-Hu Yang.
Medicine (Baltimore), 2018 May 17; 97(20). PMID: 29768327    Free PMC article.
Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort Study.
Julia E C van Steenhoven, Anne Kuijer, +12 authors, Thijs van Dalen.
Genes (Basel), 2018 May 19; 9(5). PMID: 29772837    Free PMC article.
Precision Medicine in Hormone Receptor-Positive Breast Cancer.
Azadeh Nasrazadani, Roby A Thomas, Steffi Oesterreich, Adrian V Lee.
Front Oncol, 2018 May 22; 8. PMID: 29780747    Free PMC article.
Review.
Correlations of aldehyde dehydrogenase-1 (ALDH1) expression with traditional prognostic parameters and different molecular subtypes of breast carcinoma.
Piyabi Sarkar, Keya Basu, +4 authors, Diptendra Kumar Srakar.
Clujul Med, 2018 May 23; 91(2). PMID: 29785156    Free PMC article.
Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The SOLD Randomized Clinical Trial.
Heikki Joensuu, Judith Fraser, +20 authors, Henrik Lindman.
JAMA Oncol, 2018 Jun 01; 4(9). PMID: 29852043    Free PMC article.
Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study.
Cina J Nattenmüller, Mark Kriegsmann, +13 authors, Tilman Kühn.
BMC Cancer, 2018 Jun 02; 18(1). PMID: 29855282    Free PMC article.
A nomogram to predict adjuvant chemotherapy recommendation in breast cancer patients with intermediate recurrence score.
Feilin Qu, Xiaosong Chen, +10 authors, Kunwei Shen.
Chin J Cancer Res, 2018 Jun 05; 30(2). PMID: 29861607    Free PMC article.
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.
Prudence A Francis, Olivia Pagani, +34 authors, SOFT and TEXT Investigators and the International Breast Cancer Study Group.
N Engl J Med, 2018 Jun 05; 379(2). PMID: 29863451    Free PMC article.
Highly Cited.
Role of DCE-MR in predicting breast cancer subtypes.
Marco Macchini, Martina Ponziani, +4 authors, Gian Marco Giuseppetti.
Radiol Med, 2018 Jun 06; 123(10). PMID: 29869226
The Roles of p53 in Mitochondrial Dynamics and Cancer Metabolism: The Pendulum between Survival and Death in Breast Cancer?
David E Moulder, Diana Hatoum, +2 authors, Eileen M McGowan.
Cancers (Basel), 2018 Jun 13; 10(6). PMID: 29890631    Free PMC article.
Review.
Clinical application and utility of genomic assays in early-stage breast cancer: key lessons learned to date.
S K L Chia.
Curr Oncol, 2018 Jun 19; 25(Suppl 1). PMID: 29910655    Free PMC article.
Review.
Overexpression of topoisomerase II alpha protein is a factor for poor prognosis in patients with luminal B breast cancer.
Hideo Shigematsu, Shinji Ozaki, +7 authors, Kiyomi Taniyama.
Oncotarget, 2018 Jun 22; 9(42). PMID: 29928479    Free PMC article.
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes.
Franziska Würfel, Ramona Erber, +22 authors, Matthias Rübner.
Breast Care (Basel), 2018 Jun 29; 13(1). PMID: 29950961    Free PMC article.
Lymph Node Status in Breast Cancer Does Not Predict Tumor Biology.
Danielle M Bello, Christy Russell, +2 authors, Monica Morrow.
Ann Surg Oncol, 2018 Jul 04; 25(10). PMID: 29968028    Free PMC article.
FOXA1 and AR in invasive breast cancer: new findings on their co-expression and impact on prognosis in ER-positive patients.
Nelson Rangel, Nicoletta Fortunati, +12 authors, Isabella Castellano.
BMC Cancer, 2018 Jul 05; 18(1). PMID: 29970021    Free PMC article.
Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
Rubén Rodríguez Bautista, Alette Ortega Gómez, +4 authors, Oscar Arrieta.
Clin Epigenetics, 2018 Jul 10; 10. PMID: 29983835    Free PMC article.
Review.
hERG1 channel expression associates with molecular subtypes and prognosis in breast cancer.
Jessica Iorio, Icro Meattini, +10 authors, Elena Lastraioli.
Cancer Cell Int, 2018 Jul 14; 18. PMID: 30002601    Free PMC article.
Adjuvant Subcutaneous Trastuzumab for HER2-Positive Early Breast Cancer: Subgroup Analyses of Safety and Active Medical Conditions by Body Weight in the SafeHer Phase III Study.
Kyung Hae Jung, Beyhan Ataseven, +7 authors, Hamdy A Azim.
Oncologist, 2018 Jul 19; 23(10). PMID: 30018134    Free PMC article.
Validation of Breast Cancer Models for Predicting the Nonsentinel Lymph Node Metastasis After a Positive Sentinel Lymph Node Biopsy in a Chinese Population.
Peiqi Wu, Ke Zhao, +3 authors, Changhong Liang.
Technol Cancer Res Treat, 2018 Jul 24; 17. PMID: 30033828    Free PMC article.
Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel.
Priyanka Sharma, Sara López-Tarruella, +30 authors, Miguel Martín.
Clin Cancer Res, 2018 Aug 01; 24(23). PMID: 30061361    Free PMC article.
Systematic review of the impact of breast-conserving surgery on cancer outcomes of multiple ipsilateral breast cancers.
Z E Winters, J Horsnell, +13 authors, A M Brunt.
BJS Open, 2018 Aug 07; 2(4). PMID: 30079385    Free PMC article.
Review.
Impact of combining the progesterone receptor and preoperative endocrine prognostic index (PEPI) as a prognostic factor after neoadjuvant endocrine therapy using aromatase inhibitors in postmenopausal ER positive and HER2 negative breast cancer.
Sasagu Kurozumi, Hiroshi Matsumoto, +7 authors, Hiroyuki Kuwano.
PLoS One, 2018 Aug 07; 13(8). PMID: 30080878    Free PMC article.
Breast cancer diagnosed during pregnancy is associated with enrichment of non-silent mutations, mismatch repair deficiency signature and mucin mutations.
Bastien Nguyen, David Venet, +9 authors, Christos Sotiriou.
NPJ Breast Cancer, 2018 Aug 16; 4. PMID: 30109263    Free PMC article.
Triple-Negative Breast Cancers: Systematic Review of the Literature on Molecular and Clinical Features with a Focus on Treatment with Innovative Drugs.
Anna Diana, Elisena Franzese, +8 authors, Michele Orditura.
Curr Oncol Rep, 2018 Aug 22; 20(10). PMID: 30128845
Systematic Review.
Ki 67 assessment in breast cancer in an Egyptian population: a comparative study between manual assessment on optical microscopy and digital quantitative assessment.
Essam Ayad, Ahmed Soliman, +3 authors, Youhong Dong.
Diagn Pathol, 2018 Aug 30; 13(1). PMID: 30153851    Free PMC article.
Genomic Testing in the Management of Early-Stage Breast Cancer.
Sima Ehsani, Kari Braun Wisinski.
J Clin Outcomes Manag, 2017 May 01; 24(5). PMID: 30158821    Free PMC article.
Pathway-Based Drug Repositioning for Breast Cancer Molecular Subtypes.
Raúl A Mejía-Pedroza, Jesús Espinal-Enríquez, Enrique Hernández-Lemus.
Front Pharmacol, 2018 Aug 31; 9. PMID: 30158869    Free PMC article.
PET imaging of chemokine receptor CXCR4 in patients with primary and recurrent breast carcinoma.
Tibor Vag, Katja Steiger, +7 authors, Markus Schwaiger.
EJNMMI Res, 2018 Sep 08; 8(1). PMID: 30191351    Free PMC article.
Sepsis: Personalized Medicine Utilizing 'Omic' Technologies-A Paradigm Shift?
Theis Skovsgaard Itenov, Daniel D Murray, Jens Ulrik Stæhr Jensen.
Healthcare (Basel), 2018 Sep 13; 6(3). PMID: 30205441    Free PMC article.
Review.
Is postmastectomy radiotherapy really needed in breast cancer patients with many positive axillary lymph nodes?
Tanja Marinko, Karmen Stanic.
Radiol Oncol, 2018 Sep 14; 52(3). PMID: 30210045    Free PMC article.
Molecular pathogenesis of triple-negative breast cancer based on microRNA expression signatures: antitumor miR-204-5p targets AP1S3.
Hiroko Toda, Sasagu Kurozumi, +9 authors, Naohiko Seki.
J Hum Genet, 2018 Sep 20; 63(12). PMID: 30228364
An Update on Breast Cancer Multigene Prognostic Tests-Emergent Clinical Biomarkers.
André Filipe Vieira, Fernando Schmitt.
Front Med (Lausanne), 2018 Sep 21; 5. PMID: 30234119    Free PMC article.
Review.
Differential effect of parity on rat mammary carcinogenesis after pre- or post-pubertal exposure to radiation.
Masaru Takabatake, Kazuhiro Daino, +10 authors, Yoshiya Shimada.
Sci Rep, 2018 Sep 27; 8(1). PMID: 30254198    Free PMC article.
An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project.
Giacomo Pelizzari, Grazia Arpino, +8 authors, Fabio Puglisi.
BMC Cancer, 2018 Sep 29; 18(1). PMID: 30261866    Free PMC article.
Status of FAS and FAS Ligand Gene Polymorphisms in Patients with Breast Cancer in Northeastern IRAN.
Seyed Amir Jalali, Fatemeh Homaei Shandiz, +3 authors, Mojgan Mohammadi.
Rep Biochem Mol Biol, 2018 Oct 17; 7(1). PMID: 30324114    Free PMC article.
Higher Ki67 expression in fibroblast like cells at invasive front indicates better clinical outcomes in oral squamous cell carcinoma patients.
Yue Jing, Yan Yang, +6 authors, Yanhong Ni.
Biosci Rep, 2018 Oct 21; 38(6). PMID: 30341240    Free PMC article.
UNBS5162 induces growth inhibition and apoptosis via inhibiting PI3K/AKT/mTOR pathway in triple negative breast cancer MDA-MB-231 cells.
Xin Yue, Mingzhong Li, +2 authors, Shengrong Sun.
Exp Ther Med, 2018 Oct 23; 16(5). PMID: 30344670    Free PMC article.
Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers.
Wenyong Tan, Ming Yang, +2 authors, Weixi Shen.
Cancer Manag Res, 2018 Oct 24; 10. PMID: 30349367    Free PMC article.
Review.
Effects of FGFR gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-docetaxel-based chemotherapy in breast cancer patients.
Lu Chen, Huijie Qi, +7 authors, Qunyi Li.
BMC Cancer, 2018 Oct 26; 18(1). PMID: 30359238    Free PMC article.
Targeting the Hippo Pathway for Breast Cancer Therapy.
Liqing Wu, Xiaolong Yang.
Cancers (Basel), 2018 Nov 08; 10(11). PMID: 30400599    Free PMC article.
Review.
A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA.
Sofia Salta, Sandra P Nunes, +9 authors, Carmen Jerónimo.
J Clin Med, 2018 Nov 09; 7(11). PMID: 30405052    Free PMC article.
Expression of miRNA-206 and miRNA-145 in breast cancer and correlation with prognosis.
Yan Quan, Xianxi Huang, Xiaoxiang Quan.
Oncol Lett, 2018 Nov 09; 16(5). PMID: 30405803    Free PMC article.
Correlation of tumor uptake on breast-specific gamma imaging and fluorodeoxyglucose PET/CT with molecular subtypes of breast cancer.
Soo Jin Lee, Min Sung Chung, Su-Jin Shin, Yun Young Choi.
Medicine (Baltimore), 2018 Nov 10; 97(43). PMID: 30412075    Free PMC article.
Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer.
Yoshikazu Johmura, Ichiro Maeda, +17 authors, Makoto Nakanishi.
J Clin Invest, 2018 Nov 13; 128(12). PMID: 30418174    Free PMC article.
BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer.
Mi Jeong Kwon, Sae Byul Lee, +8 authors, Young Kee Shin.
PLoS One, 2018 Nov 22; 13(11). PMID: 30462685    Free PMC article.
Association between sleep-disordered breathing and breast cancer aggressiveness.
Francisco Campos-Rodriguez, Antonio Cruz-Medina, +5 authors, Miguel Angel Martinez-Garcia.
PLoS One, 2018 Nov 22; 13(11). PMID: 30462710    Free PMC article.
Overview of the pathological results and treatment characteristics in the first 1000 patients randomized in the SERC trial: axillary dissection versus no axillary dissection in patients with involved sentinel node.
Gilles Houvenaeghel, Monique Cohen, +26 authors, Others investigators (SERC trial group).
BMC Cancer, 2018 Nov 23; 18(1). PMID: 30463611    Free PMC article.
Is Axillary Sentinel Lymph Node Biopsy Required in Patients Who Undergo Primary Breast Surgery?
Toralf Reimer, Jutta Engel, +3 authors, Oreste David Gentilini.
Breast Care (Basel), 2018 Dec 01; 13(5). PMID: 30498416    Free PMC article.
Review.
What Is the Best Management of cN0pN1(sn) Breast Cancer Patients?
Jana de Boniface, Marcus Schmidt, +3 authors, Toralf Reimer.
Breast Care (Basel), 2018 Dec 01; 13(5). PMID: 30498417    Free PMC article.
Review.
RollFISH achieves robust quantification of single-molecule RNA biomarkers in paraffin-embedded tumor tissue samples.
Chenglin Wu, Michele Simonetti, +8 authors, Mats Nilsson.
Commun Biol, 2018 Dec 05; 1. PMID: 30511022    Free PMC article.
Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial.
Guido Henke, Michael Knauer, +14 authors, Walter P Weber.
Trials, 2018 Dec 06; 19(1). PMID: 30514362    Free PMC article.
Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer.
Carina Forsare, Martin Bak, +8 authors, Mårten Fernö.
BMC Cancer, 2018 Dec 12; 18(1). PMID: 30526533    Free PMC article.
Potential clinically useful prognostic biomarkers in triple-negative breast cancer: preliminary results of a retrospective analysis.
Silvia Mihaela Ilie, Xenia Elena Bacinschi, Inga Botnariuc, Rodica Maricela Anghel.
Breast Cancer (Dove Med Press), 2018 Dec 13; 10. PMID: 30538542    Free PMC article.
Protein expression profile and microRNA expression signature in estrogen receptor-positive and -negative breast cancers: report of two cases.
Yuko Tsunoda, Akiko Sasaki, +4 authors, Eisuke Fukuma.
Breast Cancer (Dove Med Press), 2018 Dec 13; 10. PMID: 30538543    Free PMC article.
RASEF expression correlates with hormone receptor status in breast cancer.
Masahiro Shibata, Mitsuro Kanda, +13 authors, Toyone Kikumori.
Oncol Lett, 2018 Dec 14; 16(6). PMID: 30546460    Free PMC article.
Whole genome sequencing of breast cancer.
Maria Rossing, Claus Storgaard Sørensen, Bent Ejlertsen, Finn Cilius Nielsen.
APMIS, 2019 Jan 29; 127(5). PMID: 30689231    Free PMC article.
Review.
A population-based recurrence risk management study of patients with pT1 node-negative HER2+ breast cancer: a National Clinical Database study.
Makoto Kubo, Masaaki Kawai, +16 authors, Hiromitsu Jinno.
Breast Cancer Res Treat, 2019 Aug 28; 178(3). PMID: 31451979    Free PMC article.
Tumor-infiltrating lymphocytes and CD8+ T cells predict survival of triple-negative breast cancer.
H Vihervuori, T A Autere, +5 authors, P Kronqvist.
J Cancer Res Clin Oncol, 2019 Sep 29; 145(12). PMID: 31562550    Free PMC article.
Color-coded perfluorocarbon nanodroplets for multiplexed ultrasound and Photoacoustic imaging.
Daniela Y Santiesteban, Kristina A Hallam, Steven K Yarmoska, Stanislav Y Emelianov.
Nano Res, 2019 Oct 02; 12(4). PMID: 31572565    Free PMC article.
21-Gene recurrence score influences the chemotherapy decision for patients with breast cancer of different luminal subtypes.
Wei Wang, Lin Lin, +11 authors, Kunwei Shen.
Oncol Lett, 2019 Oct 04; 18(4). PMID: 31579428    Free PMC article.
Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study.
Line Moi, Tonje Braaten, +2 authors, Lill-Tove Rasmussen Busund.
J Transl Med, 2019 Oct 05; 17(1). PMID: 31581940    Free PMC article.
Prognostic Importance of Ki-67 in Breast Cancer and Its Relationship with Other Prognostic Factors.
Gül Kanyılmaz, Berrin Benli Yavuz, +3 authors, Sıddıka Fındık.
Eur J Breast Health, 2019 Oct 18; 15(4). PMID: 31620685    Free PMC article.
Hsa-miR-210-3p expression in breast cancer and its putative association with worse outcome in patients treated with Docetaxel.
Barbara Pasculli, Raffaela Barbano, +11 authors, Paola Parrella.
Sci Rep, 2019 Oct 19; 9(1). PMID: 31624308    Free PMC article.
The trans-DATA study: aims and design of a translational breast cancer prognostic marker identification study.
Tim C de Ruijter, Kim M Smits, +7 authors, Vivianne C G Tjan-Heijnen.
Diagn Progn Res, 2019 Oct 24; 3. PMID: 31641693    Free PMC article.
Exploring specific prognostic biomarkers in triple-negative breast cancer.
Chang Bao, Yunkun Lu, +5 authors, Weimin Fan.
Cell Death Dis, 2019 Oct 28; 10(11). PMID: 31649243    Free PMC article.
Impact of Nuclear Oestrogen Receptor Beta Expression in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.
Florian Heitz, Sherko Kümmel, +9 authors, Sibylle Loibl.
Geburtshilfe Frauenheilkd, 2019 Oct 28; 79(10). PMID: 31656321    Free PMC article.
Clinical significance of serum PSA in breast cancer patients.
Toru Hanamura, Koichi Ohno, +7 authors, Ken-Ichi Ito.
BMC Cancer, 2019 Oct 31; 19(1). PMID: 31664946    Free PMC article.
miR-128 Functions as an OncomiR for the Downregulation of HIC1 in Breast Cancer.
Yan Li, Ying Wang, Xiabo Shen, Xinghua Han.
Front Pharmacol, 2019 Nov 05; 10. PMID: 31680974    Free PMC article.
Neoadjuvant Chemotherapy Plays an Adverse Role in the Prognosis of Grade 2 Breast Cancer.
Xudong Zhu, Jinqi Xue, +7 authors, Yixiao Zhang.
J Cancer, 2019 Nov 19; 10(23). PMID: 31737103    Free PMC article.
Nomogram to Predict Internal Mammary Lymph Nodes Metastasis in Patients With Breast Cancer.
Xinhua Xie, Zhenchong Xiong, +4 authors, Xiaoming Xie.
Front Oncol, 2019 Nov 30; 9. PMID: 31781496    Free PMC article.
The Impact of Pathway Database Choice on Statistical Enrichment Analysis and Predictive Modeling.
Sarah Mubeen, Charles Tapley Hoyt, +3 authors, Daniel Domingo-Fernández.
Front Genet, 2019 Dec 12; 10. PMID: 31824580    Free PMC article.
Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?
Andrea Ritter, Marc Hirschfeld, +8 authors, Thalia Erbes.
Int J Oncol, 2019 Dec 04; 56(1). PMID: 31789396    Free PMC article.
ASO Author Reflections: The Changing Role of Gene Expression Profiling in ER+/HER2- Breast Cancer.
Julia E C van Steenhoven, T van Dalen.
Ann Surg Oncol, 2019 Oct 28; 26(Suppl 3). PMID: 31650304    Free PMC article.
Intracerebral Hemorrhage Induces Inflammatory Gene Expression in Peripheral Blood: Global Transcriptional Profiling in Intracerebral Hemorrhage Patients.
Kyle B Walsh, Xiang Zhang, +4 authors, Opeolu Adeoye.
DNA Cell Biol, 2019 May 24; 38(7). PMID: 31120332    Free PMC article.
Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence.
Fabio Conforti, Laura Pala, +12 authors, Aron Goldhirsch.
Breast Cancer Res, 2020 Jan 01; 21(1). PMID: 31888717    Free PMC article.
Clinical and transcriptional signatures of human CD204 reveal an applicable marker for the protumor phenotype of tumor-associated macrophages in breast cancer.
Yunjie He, Siying Zhou, +10 authors, Zuomin Zhou.
Aging (Albany NY), 2019 Dec 05; 11(23). PMID: 31799941    Free PMC article.
Ki-67 Expression is a Significant Prognostic Factor Only When Progesterone Receptor Expression is Low in Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer.
Young-Joon Kang, Han-Byoel Lee, +7 authors, Wonshik Han.
J Oncol, 2020 Jan 25; 2019. PMID: 31975992    Free PMC article.
Early metabolic response of breast cancer to neoadjuvant endocrine therapy: comparison to morphological and pathological response.
Sarah Boughdad, Laurence Champion, +5 authors, Jean-Louis Alberini.
Cancer Imaging, 2020 Jan 30; 20(1). PMID: 31992361    Free PMC article.
Low total pathologic complete response rate to preoperative chemotherapy in patients with invasive lobular carcinomaof the breast.
Parham Khosravi-Shahi, Luis Cabezón-Gutiérrez, Sara Custodio-Cabello.
Contemp Oncol (Pozn), 2020 Jan 30; 23(4). PMID: 31992958    Free PMC article.
Assessment of Ki67 expression for breast cancer subtype classification and prognosis in the Nurses' Health Study.
Megan A Healey, Kelly A Hirko, +6 authors, Aditi Hazra.
Breast Cancer Res Treat, 2017 Aug 10; 166(2). PMID: 28791482    Free PMC article.
Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review.
Tim C de Ruijter, Frank van der Heide, +3 authors, Vivianne C G Heijnen.
Breast Cancer Res, 2020 Feb 02; 22(1). PMID: 32005275    Free PMC article.
Systematic Review.
Integration of Ki-67 index into AJCC 2018 staging provides additional prognostic information in breast tumours candidate for genomic profiling.
Elena Vissio, Jasna Metovic, +7 authors, Isabella Castellano.
Br J Cancer, 2019 Nov 30; 122(3). PMID: 31780778    Free PMC article.
Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
Yunhai Li, Dejuan Yang, +8 authors, Guosheng Ren.
JAMA Netw Open, 2020 Jan 04; 3(1). PMID: 31899528    Free PMC article.
UCH-L1-mediated Down-regulation of Estrogen Receptor α Contributes to Insensitivity to Endocrine Therapy for Breast Cancer.
Xi-Sha Chen, Kuan-Song Wang, +14 authors, Yan Cheng.
Theranostics, 2020 Feb 12; 10(4). PMID: 32042339    Free PMC article.
Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer.
Battseren Bayarmaa, Ziping Wu, +6 authors, Liheng Zhou.
BMC Cancer, 2019 Sep 07; 19(1). PMID: 31488093    Free PMC article.
Gonadotropin-Releasing Hormone (GnRH) Agonists for Fertility Preservation: Is POEMS the Final Verse?
Bo Yu, Nancy E Davidson.
J Natl Cancer Inst, 2018 Oct 30; 111(2). PMID: 30371813    Free PMC article.
Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230.
Halle C F Moore, Joseph M Unger, +22 authors, Kathy S Albain.
J Natl Cancer Inst, 2018 Oct 30; 111(2). PMID: 30371800    Free PMC article.
Adjuvant chemotherapy could not bring survival benefit to HR-positive, HER2-negative, pT1b-c/N0-1/M0 invasive lobular carcinoma of the breast: a propensity score matching study based on SEER database.
Guangfu Hu, Guangxia Hu, +8 authors, Cheng Xu.
BMC Cancer, 2020 Feb 23; 20(1). PMID: 32085753    Free PMC article.
Neoadjuvant chemotherapy-induced decrease of prognostic nutrition index predicts poor prognosis in patients with breast cancer.
Takaaki Oba, Kazuma Maeno, +4 authors, Ken-Ichi Ito.
BMC Cancer, 2020 Feb 29; 20(1). PMID: 32106833    Free PMC article.
Exploring Collagen Parameters in Pure Special Types of Invasive Breast Cancer.
Rodrigo de Andrade Natal, Geisilene R Paiva, +10 authors, José Vassallo.
Sci Rep, 2019 May 24; 9(1). PMID: 31118443    Free PMC article.
Clinical outcomes of an intraoperative surgical margin assessment using the fresh frozen section method in patients with invasive breast cancer undergoing breast-conserving surgery - a single center analysis.
Tomasz Nowikiewicz, Ewa Śrutek, +3 authors, Wojciech Zegarski.
Sci Rep, 2019 Sep 19; 9(1). PMID: 31530867    Free PMC article.
Ki-67 assessment in early breast cancer: SAKK28/12 validation study on the IBCSG VIII and IBCSG IX cohort.
Zsuzsanna Varga, Qiyu Li, +7 authors, Thomas Ruhstaller.
Sci Rep, 2019 Sep 21; 9(1). PMID: 31537812    Free PMC article.
MRI Radiomic Features: Association with Disease-Free Survival in Patients with Triple-Negative Breast Cancer.
Sungwon Kim, Min Jung Kim, +2 authors, Vivian Youngjean Park.
Sci Rep, 2020 Mar 01; 10(1). PMID: 32111957    Free PMC article.
Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer.
Kathleen Van Asten, Laurence Slembrouck, +16 authors, Patrick Neven.
Oncologist, 2018 Sep 02; 24(2). PMID: 30171067    Free PMC article.
Low PR in ER(+)/HER2(-) breast cancer: high rates of TP53 mutation and high SUV.
Sung Gwe Ahn, Chang Ik Yoon, +7 authors, Joon Jeong.
Endocr Relat Cancer, 2018 Nov 09; 26(2). PMID: 30407916    Free PMC article.
PAM50 Molecular Intrinsic Subtypes in the Nurses' Health Study Cohorts.
Kevin H Kensler, Venkat N Sankar, +13 authors, Yujing J Heng.
Cancer Epidemiol Biomarkers Prev, 2018 Dec 29; 28(4). PMID: 30591591    Free PMC article.
Introduction of a New Staging System of Breast Cancer for Radiologists: An Emphasis on the Prognostic Stage.
Jieun Koh, Min Jung Kim.
Korean J Radiol, 2019 Jan 11; 20(1). PMID: 30627023    Free PMC article.
Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ.
F Magnoni, G Massari, +6 authors, V S Sacchini.
Br J Surg, 2019 Feb 23; 106(4). PMID: 30791092    Free PMC article.
Exploiting heat shock protein expression to develop a non-invasive diagnostic tool for breast cancer.
Brian T Crouch, Jennifer Gallagher, +6 authors, Nirmala Ramanujam.
Sci Rep, 2019 Mar 07; 9(1). PMID: 30837677    Free PMC article.
Breast cancer quantitative proteome and proteogenomic landscape.
Henrik J Johansson, Fabio Socciarelli, +34 authors, Janne Lehtiö.
Nat Commun, 2019 Apr 10; 10(1). PMID: 30962452    Free PMC article.
Highly Cited.
Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer.
Mustapha Abubakar, Jonine Figueroa, +8 authors, Paul D Pharoah.
Mod Pathol, 2019 Apr 13; 32(9). PMID: 30976105    Free PMC article.
A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer.
Johanna Wagner, Maria Anna Rapsomaniki, +15 authors, Bernd Bodenmiller.
Cell, 2019 Apr 16; 177(5). PMID: 30982598    Free PMC article.
Highly Cited.
Reproductive outcomes following treatment for a gynecological cancer diagnosis: a systematic review.
Brigitte Gerstl, Elizabeth Sullivan, +6 authors, Antoinette Anazodo.
J Cancer Surviv, 2019 Apr 19; 13(2). PMID: 30997658
Systematic Review.
Utility of Ki67 labeling index, cyclin D1 expression, and ER-activity level in postmenopausal ER-positive and HER2-negative breast cancer with neoadjuvant chemo-endocrine therapy.
Sasagu Kurozumi, Yuri Yamaguchi, +6 authors, Kenichi Inoue.
PLoS One, 2019 May 22; 14(5). PMID: 31112577    Free PMC article.
A simple immunohistochemical bio-profile incorporating Bcl2 curbs those cases of invasive breast carcinoma for which an Oncotype Dx characterization is needed.
Claudio Ceccarelli, Antonio De Leo, +5 authors, Donatella Santini.
PLoS One, 2019 Jun 04; 14(6). PMID: 31158261    Free PMC article.
Extracting Pathway-level Signatures from Proteogenomic Data in Breast Cancer Using Independent Component Analysis.
Wenke Liu, Samuel H Payne, Sisi Ma, David Fenyö.
Mol Cell Proteomics, 2019 Jun 20; 18(8 suppl 1). PMID: 31213479    Free PMC article.
Ki-67, an elusive marker in the prognosis of breast cancer.
Neelam Sood.
Indian J Med Res, 2019 Nov 14; 150(3). PMID: 31719290    Free PMC article.
Diagnostic ability of real-time quantitative polymerase chain reaction versus immunohistochemistry for Ki-67 assessment in breast cancer: An Indian perspective.
Anurag Mehta, Dushyant Kumar, +5 authors, Ajit Panaych.
Indian J Med Res, 2019 Nov 14; 150(3). PMID: 31719296    Free PMC article.
N-Cadherin mRNA Levels in Peripheral Blood Could Be a Potential Indicator of New Metastases in Breast Cancer: A Pilot Study.
Takaaki Masuda, Hiroki Ueo, +12 authors, Hiroaki Ueo.
Int J Mol Sci, 2020 Jan 18; 21(2). PMID: 31947504    Free PMC article.
Single Tumor Cells With Epithelial-Like Morphology Are Associated With Breast Cancer Metastasis.
Liubov A Tashireva, Marina V Zavyalova, +4 authors, Vladimir M Perelmuter.
Front Oncol, 2020 Mar 11; 10. PMID: 32154161    Free PMC article.
Predictive factors of 5-year relapse-free survival in HR+/HER2- breast cancer patients treated with neoadjuvant endocrine therapy: pooled analysis of two phase 2 trials.
Florence Lerebours, Marina Pulido, +17 authors, Nathalie Quenel-Tueux.
Br J Cancer, 2020 Feb 01; 122(6). PMID: 32001832    Free PMC article.
Inhibition of the PI3K-AKT-mTOR pathway suppresses the adipocyte-mediated proliferation and migration of breast cancer cells.
Jae-Yeo Park, Shi-Eun Kang, +4 authors, Seok-Geun Lee.
J Cancer, 2020 Mar 24; 11(9). PMID: 32201525    Free PMC article.
Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor-Positive Metastatic Breast Cancer.
Nicholas C Turner, Yuan Liu, +13 authors, Massimo Cristofanilli.
J Clin Oncol, 2019 Feb 27; 37(14). PMID: 30807234    Free PMC article.
Highly Cited.
Clinical Interest of Combining Transcriptomic and Genomic Signatures in High-Grade Serous Ovarian Cancer.
Yann Kieffer, Claire Bonneau, +3 authors, Fatima Mechta-Grigoriou.
Front Genet, 2020 Apr 08; 11. PMID: 32256521    Free PMC article.
Axillary nodal involvement by primary tumor features in early breast cancer: an analysis of 2600 patients.
M C De Santis, E La Rocca, +13 authors, S Di Cosimo.
Clin Transl Oncol, 2019 Aug 03; 22(5). PMID: 31372896
Absence of Nuclear p16 Is a Diagnostic and Independent Prognostic Biomarker in Squamous Cell Carcinoma of the Cervix.
Saioa Mendaza, Joaquín Fernández-Irigoyen, +9 authors, Esperanza Martín-Sánchez.
Int J Mol Sci, 2020 Mar 25; 21(6). PMID: 32204550    Free PMC article.
The Correlation of Magee EquationsTM and Oncotype DX® Recurrence Score From Core Needle Biopsy Tissues in Predicting Response to Neoadjuvant Chemotherapy in ER+ and HER2- Breast Cancer.
Atilla Soran, Kaori Tane, Efe Sezgin, Rohit Bhargava.
Eur J Breast Health, 2020 Apr 15; 16(2). PMID: 32285033    Free PMC article.
Autophagy Inhibition Induces the Secretion of Macrophage Migration Inhibitory Factor (MIF) with Autocrine and Paracrine Effects on the Promotion of Malignancy in Breast Cancer.
Israel Cotzomi-Ortega, Arely Rosas-Cruz, +4 authors, Paola Maycotte.
Biology (Basel), 2020 Jan 23; 9(1). PMID: 31963754    Free PMC article.
Although c‑MYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ER‑positive breast cancer.
Rui Chen, Shipeng Guo, +7 authors, Shengchun Liu.
Int J Oncol, 2020 Apr 23; 56(4). PMID: 32319562    Free PMC article.
Breast Cancer 18F-ISO-1 Uptake as a Marker of Proliferation Status.
Elizabeth S McDonald, Robert K Doot, +14 authors, David A Mankoff.
J Nucl Med, 2019 Dec 15; 61(5). PMID: 31836680    Free PMC article.
Tumour characteristics and survivorship in a cohort of breast cancer: the MCC-Spain study.
Inés Gómez-Acebo, Trinidad Dierssen-Sotos, +22 authors, Javier Llorca.
Breast Cancer Res Treat, 2020 May 02; 181(3). PMID: 32356254    Free PMC article.
Targeting claudin-4 enhances chemosensitivity in breast cancer.
Yi Luo, Shingo Kishi, +9 authors, Hiroki Kuniyasu.
Cancer Sci, 2020 Feb 23; 111(5). PMID: 32086991    Free PMC article.
Leptin Signaling Contributes to Aromatase Inhibitor Resistant Breast Cancer Cell Growth and Activation of Macrophages.
Luca Gelsomino, Cinzia Giordano, +12 authors, Stefania Catalano.
Biomolecules, 2020 Apr 09; 10(4). PMID: 32260113    Free PMC article.
Utilization of genetic testing in breast cancer treatment after implementation of comprehensive multi-disciplinary care.
Samfee Doe, Shariska Petersen, Monique Swain.
Breast J, 2020 Jan 10; 26(5). PMID: 31916345    Free PMC article.
Strategies to Improve Recruitment to a De-escalation Trial: A Mixed-Methods Study of the OPTIMA Prelim Trial in Early Breast Cancer.
C Conefrey, J L Donovan, +18 authors, OPTIMA Prelim Study Group.
Clin Oncol (R Coll Radiol), 2020 Feb 25; 32(6). PMID: 32089356    Free PMC article.
Clinicopathological and prognostic significance of nestin expression in patients with breast cancer: a systematic review and meta-analysis.
Xinyi Zhang, Changsheng Xing, +4 authors, Kai Xie.
Cancer Cell Int, 2020 May 30; 20. PMID: 32467665    Free PMC article.
Pathological and genetic aspects of spontaneous mammary gland tumor in Tupaia belangeri (tree shrew).
Chi Hai-Ying, Yuki Tanaka, +13 authors, Kyoko Tsukiyama-Kohara.
PLoS One, 2020 May 19; 15(5). PMID: 32421739    Free PMC article.
Automated quantitative analysis of Ki-67 staining and HE images recognition and registration based on whole tissue sections in breast carcinoma.
Min Feng, Yang Deng, +10 authors, Hong Bu.
Diagn Pathol, 2020 May 31; 15(1). PMID: 32471471    Free PMC article.
Ki-67 response-guided preoperative chemotherapy for HER2-positive breast cancer: results of a randomised Phase 2 study.
Hirofumi Mukai, Takeshi Yamaguchi, +14 authors, Yukari Uemura.
Br J Cancer, 2020 Apr 03; 122(12). PMID: 32238920    Free PMC article.
A prognostic model based on cell-cycle control predicts outcome of breast cancer patients.
Heli Repo, Eliisa Löyttyniemi, +4 authors, Pauliina Kronqvist.
BMC Cancer, 2020 Jun 18; 20(1). PMID: 32546141    Free PMC article.
Biomarkers of tumor invasiveness in proteomics (Review).
Daniel L Pouliquen, Alice Boissard, Olivier Coqueret, Catherine Guette.
Int J Oncol, 2020 May 30; 57(2). PMID: 32468071    Free PMC article.
Association of Sperm-Associated Antigen 5 and Treatment Response in Patients With Estrogen Receptor-Positive Breast Cancer.
Tarek M A Abdel-Fatah, Graham R Ball, +14 authors, Stephen Y T Chan.
JAMA Netw Open, 2020 Jul 08; 3(7). PMID: 32633764    Free PMC article.
Variability in hospital treatment costs: a time-driven activity-based costing approach for early-stage invasive breast cancer patients.
Erin Roman, Brecht Cardoen, Jan Decloedt, Filip Roodhooft.
BMJ Open, 2020 Jul 10; 10(7). PMID: 32641325    Free PMC article.
Identification of a Profile of Neutrophil-Derived Granule Proteins in the Surface of Gold Nanoparticles after Their Interaction with Human Breast Cancer Sera.
María Del Pilar Chantada-Vázquez, María García-Vence, +2 authors, Cristina Núñez.
Nanomaterials (Basel), 2020 Jun 27; 10(6). PMID: 32586001    Free PMC article.
A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer.
Claire Bonneau, Antoine Eliès, +9 authors, Fatima Mechta-Grigoriou.
Breast Cancer Res, 2020 Jul 16; 22(1). PMID: 32665033    Free PMC article.
Association among T2 signal intensity, necrosis, ADC and Ki-67 in estrogen receptor-positive and HER2-negative invasive ductal carcinoma.
Soo-Yeon Kim, Eun-Kyung Kim, +4 authors, Min Jung Kim.
Magn Reson Imaging, 2018 Sep 03; 54. PMID: 30172938    Free PMC article.
Prognostic potential of automated Ki67 evaluation in breast cancer: different hot spot definitions versus true global score.
Stephanie Robertson, Balazs Acs, Michael Lippert, Johan Hartman.
Breast Cancer Res Treat, 2020 Jun 24; 183(1). PMID: 32572716    Free PMC article.
Risk stratification in luminal-type breast cancer: Comparison of Ki-67 with EndoPredict test results.
Aurelia Noske, Sophie-Isabelle Anders, +6 authors, Evelyn Klein.
Breast, 2019 Dec 02; 49. PMID: 31786414    Free PMC article.
Decision of adjuvant chemotherapy in intermediate risk luminal breast cancer patients: A prospective multicenter trial assessing the clinical and psychological impact of EndoPredict® (EpClin) use (UCBG 2-14).
Frédérique Penault-Llorca, Fabrice Kwiatkowski, +18 authors, Suzette Delaloge.
Breast, 2019 Dec 04; 49. PMID: 31790959    Free PMC article.
AGR3 promotes estrogen receptor-positive breast cancer cell proliferation in an estrogen-dependent manner.
Lei Jian, Jian Xie, +6 authors, Shengchun Liu.
Oncol Lett, 2020 Jul 30; 20(2). PMID: 32724387    Free PMC article.
Methylation of WT1, CA10 in peripheral blood leukocyte is associated with breast cancer risk: a case-control study.
Anqi Ge, Song Gao, +5 authors, Yashuang Zhao.
BMC Cancer, 2020 Aug 02; 20(1). PMID: 32736539    Free PMC article.
Multiparametric MRI-based radiomics analysis for the prediction of breast tumor regression patterns after neoadjuvant chemotherapy.
Xiaosheng Zhuang, Chi Chen, +10 authors, Kun Wang.
Transl Oncol, 2020 Aug 08; 13(11). PMID: 32759037    Free PMC article.
FBXO22, an epigenetic multiplayer coordinating senescence, hormone signaling, and metastasis.
Yoshikazu Johmura, Alexander S Harris, Tomohiko Ohta, Makoto Nakanishi.
Cancer Sci, 2020 Jun 15; 111(8). PMID: 32536008    Free PMC article.
Review.
Predictive and prognostic value of EPIC1 in patients with breast cancer receiving neoadjuvant chemotherapy.
Yaqian Xu, Yan Wang, +11 authors, Jinsong Lu.
Ther Adv Med Oncol, 2020 Aug 13; 12. PMID: 32782487    Free PMC article.
The TP53 mutation rate differs in breast cancers that arise in women with high or low mammographic density.
Dane Cheasley, Lisa Devereux, +16 authors, Ian G Campbell.
NPJ Breast Cancer, 2020 Aug 18; 6. PMID: 32802943    Free PMC article.
Management of early breast cancer during the COVID-19 pandemic in Brazil.
Francisco Pimentel Cavalcante, Guilherme Garcia Novita, +4 authors, Ruffo Freitas Junior.
Breast Cancer Res Treat, 2020 Aug 18; 184(2). PMID: 32803637    Free PMC article.
Discordance in 21-gene recurrence scores between paired breast cancer samples is inversely associated with patient age.
Sarah M Bernhardt, Pallave Dasari, +6 authors, Wendy V Ingman.
Breast Cancer Res, 2020 Aug 20; 22(1). PMID: 32811558    Free PMC article.
Identification and validation of stemness-related lncRNA prognostic signature for breast cancer.
Xiaoying Li, Yang Li, Xinmiao Yu, Feng Jin.
J Transl Med, 2020 Sep 02; 18(1). PMID: 32867770    Free PMC article.
Predicting Expected Absolute Chemotherapy Treatment Benefit in Women With Early-Stage Breast Cancer Using EndoPredict, an Integrated 12-Gene Clinicomolecular Assay.
Hatem Soliman, Darl D Flake, +10 authors, William Gradishar.
JCO Precis Oncol, 2020 Sep 12; 3. PMID: 32914026    Free PMC article.
Examination of Tumor Regression Grading Systems in Breast Cancer Patients Who Received Neoadjuvant Therapy.
Anita Sejben, Renáta Kószó, +2 authors, Tamás Zombori.
Pathol Oncol Res, 2020 Jul 22; 26(4). PMID: 32691390    Free PMC article.
Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer.
Taru A Muranen, Sofia Khan, +41 authors, Heli Nevanlinna.
NPJ Breast Cancer, 2020 Sep 24; 6. PMID: 32964118    Free PMC article.
Clinical Differences in Triple-Positive Operable Breast Cancer Subtypes in Korean Patients: An Analysis of Korean Breast Cancer Registry Data.
Sun Hyong You, Byung Joo Chae, +4 authors, Woo-Chan Park.
J Breast Cancer, 2019 Jan 05; 21(4). PMID: 30607163    Free PMC article.
Improved prognosis of low baseline neutrophil-to-lymphocyte ratio is significantly exclusive in breast cancer patients with high absolute counts of lymphocytes.
Yukie Fujimoto, Hiromi Ozawa, +4 authors, Yasuo Miyoshi.
Mol Clin Oncol, 2019 Jan 27; 10(2). PMID: 30680208    Free PMC article.
Impact of clinical and pathological factors on local recurrence after breast-conserving treatment: CT-based localization for a tumor bed boost yielded better local control when compared with a surgical scar.
Lize Wang, Jinfeng Li, +4 authors, Tao Ouyang.
J Cancer, 2019 Feb 06; 10(3). PMID: 30719169    Free PMC article.

Anca Zgura, Laurentia Galesa, Elvira Bratila, Rodica Anghel.
Maedica (Bucur), 2019 Feb 19; 13(4). PMID: 30774731    Free PMC article.
Analysis of Treg cell population in patients with breast cancer with respect to progesterone receptor status.
Konrad Dziobek, Marta Biedka, +3 authors, Magdalena Dutsch-Wicherek.
Contemp Oncol (Pozn), 2019 Feb 21; 22(4). PMID: 30783387    Free PMC article.
Comparison of the 7th and 8th edition of American Joint Committee on Cancer (AJCC) staging systems for breast cancer patients: a Surveillance, Epidemiology and End Results (SEER) Analysis.
Nan Shao, Chuanbo Xie, +6 authors, Ying Lin.
Cancer Manag Res, 2019 Mar 14; 11. PMID: 30863154    Free PMC article.
Aligning the Aligners: Comparison of RNA Sequencing Data Alignment and Gene Expression Quantification Tools for Clinical Breast Cancer Research.
Isaac D Raplee, Alexei V Evsikov, Caralina Marín de Evsikova.
J Pers Med, 2019 Apr 17; 9(2). PMID: 30987214    Free PMC article.
Gonadotropin-releasing hormone agonists during chemotherapy for ovarian function and fertility preservation for patients with early-stage breast cancer.
Hikmat Abdel-Razeq.
Cancer Manag Res, 2019 Jun 14; 11. PMID: 31190993    Free PMC article.
Review.
Should a Multigene Signature be Used in all Luminal Early Breast Cancers.
Nawale Hajjaji, Yves Marie Robin, Jacques Bonneterre.
Front Oncol, 2019 Jun 20; 9. PMID: 31214499    Free PMC article.
Breast Cancer Subtypes Present a Differential Production of Reactive Oxygen Species (ROS) and Susceptibility to Antioxidant Treatment.
Fabiola Lilí Sarmiento-Salinas, Alam Delgado-Magallón, +9 authors, Paola Maycotte.
Front Oncol, 2019 Jun 25; 9. PMID: 31231612    Free PMC article.
Paradigm Shift From Halstedian Radical Mastectomy to Personalized Medicine.
Vahit Özmen.
J Breast Health, 2017 Apr 01; 13(2). PMID: 31244529    Free PMC article.
Review.
Young-onset breast cancer: a poor prognosis only exists in low-risk patients.
Jianfei Fu, Lunpo Wu, +7 authors, Jinlin Du.
J Cancer, 2019 Jul 11; 10(14). PMID: 31289582    Free PMC article.
The prognosis comparison of different molecular subtypes of breast tumors after radiotherapy and the intrinsic reasons for their distinct radiosensitivity.
Lin He, Yang Lv, Yuhua Song, Biyuan Zhang.
Cancer Manag Res, 2019 Jul 16; 11. PMID: 31303789    Free PMC article.
Review.
Clinicopathological and epidemiological significance of breast cancer subtype reclassification based on p53 immunohistochemical expression.
Mustapha Abubakar, Changyuan Guo, +9 authors, Xiaohong R Yang.
NPJ Breast Cancer, 2019 Aug 03; 5. PMID: 31372496    Free PMC article.
Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer.
Mi Jeong Kwon, Jeong Eon Lee, +12 authors, Young Kee Shin.
Front Oncol, 2019 Aug 14; 9. PMID: 31404265    Free PMC article.
Fertility Preservation Using GnRH Agonists: Rationale, Possible Mechanisms, and Explanation of Controversy.
Zeev Blumenfeld.
Clin Med Insights Reprod Health, 2019 Sep 07; 13. PMID: 31488958    Free PMC article.
Review.
Robust and interpretable PAM50 reclassification exhibits survival advantage for myoepithelial and immune phenotypes.
James C Mathews, Saad Nadeem, +3 authors, Allen Tannenbaum.
NPJ Breast Cancer, 2019 Sep 19; 5. PMID: 31531391    Free PMC article.
Construction of Nomograms for Predicting Pathological Complete Response and Tumor Shrinkage Size in Breast Cancer.
Shuai Yan, Wenjie Wang, +3 authors, Weiyang Tao.
Cancer Manag Res, 2020 Sep 29; 12. PMID: 32982426    Free PMC article.
Genomic Signatures in Luminal Breast Cancer.
Julian Puppe, Tabea Seifert, +3 authors, Wolfram Malter.
Breast Care (Basel), 2020 Sep 29; 15(4). PMID: 32982645    Free PMC article.
Review.
Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimens.
Kristina A Tendl-Schulz, Fabian Rössler, +15 authors, Zsuzsanna Bago-Horvath.
Virchows Arch, 2020 May 10; 477(4). PMID: 32383007    Free PMC article.
Breast cancer subtypes: implications for the treatment and survival of patients in Africa-a prospective cohort study from Mozambique.
Mariana Brandão, Assucena Guisseve, +13 authors, Nuno Lunet.
ESMO Open, 2020 Oct 07; 5(5). PMID: 33020218    Free PMC article.
Elevated Expression of RIOK1 Is Correlated with Breast Cancer Hormone Receptor Status and Promotes Cancer Progression.
Zhiqi Huang, Xingyu Li, +5 authors, Chunhui Zhang.
Cancer Res Treat, 2020 Jul 01; 52(4). PMID: 32599985    Free PMC article.
Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC.
Luca Campedel, Paul Blanc-Durand, +15 authors, Sylvie Giacchetti.
Cancers (Basel), 2020 Sep 23; 12(9). PMID: 32957722    Free PMC article.
Validation of Clinical Treatment Score post-5 years (CTS5) risk stratification in premenopausal breast cancer patients and Ki-67 labelling index.
Janghee Lee, Chihwan Cha, +9 authors, Joon Jeong.
Sci Rep, 2020 Oct 10; 10(1). PMID: 33033359    Free PMC article.
Development and validation of a novel stem cell subtype for bladder cancer based on stem genomic profiling.
Chaozhi Tang, Jiakang Ma, Xiuli Liu, Zhengchun Liu.
Stem Cell Res Ther, 2020 Oct 30; 11(1). PMID: 33115513    Free PMC article.
Cost-effectiveness analyses demonstrate that observation is superior to sentinel lymph node biopsy for postmenopausal women with HR + breast cancer and negative axillary ultrasound.
Aubriana M McEvoy, Steven Poplack, +7 authors, William E Gillanders.
Breast Cancer Res Treat, 2020 Jul 12; 183(2). PMID: 32651755    Free PMC article.
Review.
Performance of Automated Dissection on Formalin-Fixed Paraffin-Embedded Tissue Sections for the 21-Gene Recurrence Score Assay.
Peng Qi, Qian-Ming Bai, +2 authors, Xiao-Yan Zhou.
Technol Cancer Res Treat, 2020 Oct 20; 19. PMID: 33073677    Free PMC article.
HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients.
Xudong Zhu, Yixiao Zhang, +10 authors, Caigang Liu.
Int J Med Sci, 2020 Nov 10; 17(17). PMID: 33162805    Free PMC article.
Identification of Novel BRCA1 and RAD50 Mutations Associated With Breast Cancer Predisposition in Tunisian Patients.
Najah Mighri, Yosr Hamdi, +15 authors, Sonia Abdelhak.
Front Genet, 2020 Nov 27; 11. PMID: 33240314    Free PMC article.
Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial.
Ulrike Nitz, Oleg Gluz, +18 authors, Nadia Harbeck.
Breast Cancer Res Treat, 2017 Jul 01; 165(3). PMID: 28664507    Free PMC article.
MammaPrint versus EndoPredict: Poor correlation in disease recurrence risk classification of hormone receptor positive breast cancer.
Andreas Bösl, Andreas Spitzmüller, +3 authors, Felix Offner.
PLoS One, 2017 Aug 30; 12(8). PMID: 28850621    Free PMC article.
Omitting Adjuvant Radiotherapy for Hormone Receptor‒Positive Early-Stage Breast Cancer in Old Age: A Propensity Score Matched SEER Analysis.
Yi-Jun Kim, Kyung Hwan Shin, Kyubo Kim.
Cancer Res Treat, 2018 May 12; 51(1). PMID: 29747486    Free PMC article.
Neoadjuvant chemoradiation and breast reconstruction: the potential for improved outcomes in the treatment of breast cancer.
Niamh O' Halloran, Terri McVeigh, +3 authors, Michael Kerin.
Ir J Med Sci, 2018 Jun 28; 188(1). PMID: 29948462
Expression of survivin does not appear to influence breast cancer recurrence risk.
Lindsay J Collin, Deirdre P Cronin-Fenton, +9 authors, Timothy L Lash.
Acta Oncol, 2018 Oct 24; 58(2). PMID: 30351173    Free PMC article.
Rho GTPase Activating Protein 24 (ARHGAP24) Regulates the Anti-Cancer Activity of Sorafenib Against Breast Cancer MDA-MB-231 Cells via the Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway.
Xianping Dai, Feng Geng, +2 authors, Ming Liu.
Med Sci Monit, 2018 Dec 01; 24. PMID: 30499465    Free PMC article.
CD1d- and PJA2-related immune microenvironment differs between invasive breast carcinomas with and without a micropapillary feature.
Naoki Kanomata, Junichi Kurebayashi, +2 authors, Takuya Moriya.
BMC Cancer, 2019 Jan 18; 19(1). PMID: 30651076    Free PMC article.
Re-testing of predictive biomarkers on surgical breast cancer specimens is clinically relevant.
Stephanie Robertson, Caroline Rönnlund, Jana de Boniface, Johan Hartman.
Breast Cancer Res Treat, 2019 Jan 20; 174(3). PMID: 30659433    Free PMC article.
Real-world data on discordance between estrogen, progesterone, and HER2 receptor expression on diagnostic tumor biopsy versus tumor resection material.
A M Sofie Berghuis, Carolien H M van Deurzen, +3 authors, Maarten J IJzerman.
Breast Cancer Res Treat, 2019 Feb 14; 175(2). PMID: 30756285    Free PMC article.
Higher axillary lymph node metastasis burden in breast cancer patients with positive preoperative node biopsy: may not be appropriate to receive sentinel lymph node biopsy in the post-ACOSOG Z0011 trial era.
Yue Liang, Xiaosong Chen, +9 authors, Kunwei Shen.
World J Surg Oncol, 2019 Feb 23; 17(1). PMID: 30786903    Free PMC article.
Hormone- and HER2-receptor assessment in 33,046 breast cancer patients: a nationwide comparison of positivity rates between pathology laboratories in the Netherlands.
Carmen van Dooijeweert, Ivette A G Deckers, +2 authors, Paul J van Diest.
Breast Cancer Res Treat, 2019 Mar 03; 175(2). PMID: 30825048    Free PMC article.
Identification and clinical validation of a multigene assay that interrogates the biology of cancer stem cells and predicts metastasis in breast cancer: A retrospective consecutive study.
Salvatore Pece, Davide Disalvatore, +8 authors, Pier Paolo Di Fiore.
EBioMedicine, 2019 Mar 09; 42. PMID: 30846393    Free PMC article.
Quantification of intrinsic subtype ambiguity in Luminal A breast cancer and its relationship to clinical outcomes.
Neeraj Kumar, Dan Zhao, +2 authors, Peter H Gann.
BMC Cancer, 2019 Mar 10; 19(1). PMID: 30849944    Free PMC article.
The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status.
Anna Glajcar, Joanna Szpor, +2 authors, Krzysztof Okoń.
Virchows Arch, 2019 Apr 25; 475(1). PMID: 31016433    Free PMC article.
In-cell determination of Lactate Dehydrogenase Activity in a Luminal Breast Cancer Model ⁻ ex vivo Investigation of Excised Xenograft Tumor Slices Using dDNP Hyperpolarized [1-13C]pyruvate.
Yael Adler-Levy, Atara Nardi-Schreiber, +8 authors, Rachel Katz-Brull.
Sensors (Basel), 2019 May 08; 19(9). PMID: 31060334    Free PMC article.
Phospho‑STAT1 expression as a potential biomarker for anti‑PD‑1/anti‑PD‑L1 immunotherapy for breast cancer.
Yuko Nakayama, Kosaku Mimura, +11 authors, Koji Kono.
Int J Oncol, 2019 May 14; 54(6). PMID: 31081058    Free PMC article.
Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes.
Chih Wan Goh, Jiayi Wu, +7 authors, Li Zhu.
J Cancer Res Clin Oncol, 2019 May 16; 145(7). PMID: 31089799
Clinicopathological Features and Disease Outcome in Breast Cancer Patients with Hormonal Receptor Discordance between Core Needle Biopsy and Following Surgical Sample.
Siji Zhu, Jiayi Wu, +7 authors, Kunwei Shen.
Ann Surg Oncol, 2019 May 31; 26(9). PMID: 31144143    Free PMC article.
Which of the fluorine-18 fluorodeoxyglucose positron emission tomography/computerized tomography parameters are better associated with prognostic factors in breast cancer?
Hasan Önner, Funda Canaz, +4 authors, Serdar Erkasap.
Medicine (Baltimore), 2019 May 31; 98(22). PMID: 31145358    Free PMC article.
Array comparative genomic hybridization analysis discloses chromosome copy number alterations as indicators of patient outcome in lymph node-negative breast cancer.
Ryoko Kikuchi-Koike, Kazunori Nagasaka, +14 authors, Takuya Ayabe.
BMC Cancer, 2019 May 31; 19(1). PMID: 31146704    Free PMC article.
PROGNOSTIC IMPACT OF LOW ESTROGEN AND PROGESTERONE POSITIVITY IN LUMINAL B (HER2 NEGATIVE) BREAST CANCER.
Jasmina Rajc, Irena Fröhlich, +2 authors, Josipa Flam.
Acta Clin Croat, 2019 Jun 07; 57(3). PMID: 31168174    Free PMC article.
Prognostic Factors for Luminal B-like Breast Cancer.
Nian-Hua Ding, Cong-Fan Liu, +3 authors, Zhi Xiao.
Curr Med Sci, 2019 Jun 19; 39(3). PMID: 31209809
Differentially Expressed Mitochondrial Proteins in Human MCF7 Breast Cancer Cells Resistant to Paclitaxel.
Petr Daniel, Petr Halada, +2 authors, Jan Kovář.
Int J Mol Sci, 2019 Jun 30; 20(12). PMID: 31248089    Free PMC article.
Microfluidic-based immunohistochemistry for breast cancer diagnosis: a comparative clinical study.
Fabio Aimi, Maria-Giuseppina Procopio, +6 authors, Laurence de Leval.
Virchows Arch, 2019 Jul 04; 475(3). PMID: 31267199
Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy.
Mark Laible, Kerstin Hartmann, +7 authors, Annette Ramaswamy.
BMC Cancer, 2019 Jul 17; 19(1). PMID: 31307414    Free PMC article.
The Role of Exosomal MicroRNAs in the Tumor Microenvironment of Breast Cancer.
Qingqing Liu, Fu Peng, Jianping Chen.
Int J Mol Sci, 2019 Aug 10; 20(16). PMID: 31395836    Free PMC article.
Review.
Efficacy of chemotherapy for lymph node-positive luminal A subtype breast cancer patients: an updated meta-analysis.
Yilun Li, Li Ma.
World J Surg Oncol, 2020 Dec 04; 18(1). PMID: 33267822    Free PMC article.
Review.
Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells.
Clara Gómez-Aleza, Bastien Nguyen, +31 authors, Eva González-Suárez.
Nat Commun, 2020 Dec 12; 11(1). PMID: 33303745    Free PMC article.
Towards personalized treatment for early stage HER2-positive breast cancer.
Kristina Goutsouliak, Jamunarani Veeraraghavan, +4 authors, Rachel Schiff.
Nat Rev Clin Oncol, 2019 Dec 15; 17(4). PMID: 31836877
Review.
Impact of Commercialized Genomic Tests on Adjuvant Treatment Decisions in Early Stage Breast Cancer Patients.
Hazem I Assi, Ibrahim A Alameh, +9 authors, Nagi El Saghir.
J Oncol, 2020 Dec 15; 2020. PMID: 33312202    Free PMC article.
Ki67 Immunohistochemistry Quantification in Breast Carcinoma: A Comparison of Visual Estimation, Counting, and ImmunoRatio.
Eunice J van den Berg, Raquel Duarte, +2 authors, Reena Mohanlal.
Appl Immunohistochem Mol Morphol, 2020 Jun 27; 29(2). PMID: 32590453    Free PMC article.
Can MRI Biomarkers Predict Triple-Negative Breast Cancer?
Giuliana Moffa, Francesca Galati, +4 authors, Federica Pediconi.
Diagnostics (Basel), 2020 Dec 19; 10(12). PMID: 33333733    Free PMC article.
Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study.
Nancy K Gillis, Markus Ball, +15 authors, Eric Padron.
Lancet Oncol, 2016 Dec 09; 18(1). PMID: 27927582    Free PMC article.
Highly Cited.
The role of chemotherapy in patients with T1bN0M0 triple-negative breast cancer: a real-world competing risk analysis.
Tian Lan, Yunyan Lu, +4 authors, Zujian Hu.
J Cancer, 2021 Jan 05; 12(1). PMID: 33391398    Free PMC article.
Prognostic and Predictive Value of the American Joint Committee on Cancer Pathological Prognostic Staging System in Nodal Micrometastatic Breast Cancer.
Jian Shi, Chen-Lu Lian, +6 authors, San-Gang Wu.
Front Oncol, 2021 Jan 05; 10. PMID: 33392071    Free PMC article.
The implementation of a commercially available multi-gene profile test for breast cancer characterization in a department of pathology: what have we learned from the first 100 cases?
Cristina Pelliccia, Emanuele Caselli, +3 authors, Angelo Sidoni.
Virchows Arch, 2021 Jan 07;. PMID: 33404851
Behavior of metastatic breast cancer according to subtype.
Margot Van Mechelen, Anke Van Herck, +9 authors, Hans Wildiers.
Breast Cancer Res Treat, 2020 Mar 21; 181(1). PMID: 32193802
A novel immune prognostic index for stratification of high-risk patients with early breast cancer.
Hannah Lee, Mi Jeong Kwon, +3 authors, Young Kee Shin.
Sci Rep, 2021 Jan 10; 11(1). PMID: 33420250    Free PMC article.
The Changing Role of Gene-Expression Profiling in the Era of De-escalating Adjuvant Chemotherapy in Early-Stage Breast Cancer.
J E C van Steenhoven, A Kuijer, +5 authors, T van Dalen.
Ann Surg Oncol, 2019 Jun 19; 26(11). PMID: 31209664    Free PMC article.
Addition of carboplatin-gemcitabine as second-line neoadjuvant chemotherapy in non-responsive locally advanced breast cancer patients to standard neoadjuvant chemotherapy and evaluation of factors affecting response: a randomized controlled trial.
Dena Firouzabadi, Amirreza Dehghanian, +2 authors, Abdolrasoul Talei.
BMC Cancer, 2021 Jan 13; 21(1). PMID: 33430808    Free PMC article.
Concordance of the 21-gene assay between core needle biopsy and resection specimens in early breast cancer patients.
Peng Qi, Yu Yang, +5 authors, Xiao-Yan Zhou.
Breast Cancer Res Treat, 2021 Jan 14;. PMID: 33439420    Free PMC article.
SOX12 expression is associated with progression and poor prognosis in human breast cancer.
Junming Xu, Jinyan Zhang, +3 authors, Yang Li.
Am J Transl Res, 2021 Jan 14; 12(12). PMID: 33437389    Free PMC article.
A novel autophagy-related lncRNA prognostic risk model for breast cancer.
Xiaoying Li, Feng Jin, Yang Li.
J Cell Mol Med, 2020 Nov 21; 25(1). PMID: 33216456    Free PMC article.
Review.
Recent Discoveries of Macromolecule- and Cell-Based Biomarkers and Therapeutic Implications in Breast Cancer.
Hsing-Ju Wu, Pei-Yi Chu.
Int J Mol Sci, 2021 Jan 14; 22(2). PMID: 33435254    Free PMC article.
Review.
Predicting of Sentinel Lymph Node Status in Breast Cancer Patients with Clinically Negative Nodes: A Validation Study.
Annarita Fanizzi, Domenico Pomarico, +11 authors, Raffaella Massafra.
Cancers (Basel), 2021 Jan 23; 13(2). PMID: 33477893    Free PMC article.
Impact of genetic variants in IL-2RA and IL-2RB on breast cancer risk in Chinese Han women.
Lingge He, Wenjie Zhang, +6 authors, Tianbo Jin.
Biochem Genet, 2021 Jan 29;. PMID: 33507447
Imaging features of breast cancer molecular subtypes: state of the art.
Nariya Cho.
J Pathol Transl Med, 2020 Nov 07; 55(1). PMID: 33153242    Free PMC article.
Review.
IQGAP3 Overexpression Correlates With Poor Prognosis and Radiation Therapy Resistance in Breast Cancer.
Xin Hua, Zhi-Qing Long, +3 authors, Wen-Wen Zhang.
Front Pharmacol, 2021 Feb 02; 11. PMID: 33519444    Free PMC article.
In modern times, how important are breast cancer stage, grade and receptor subtype for survival: a population-based cohort study.
Anna L V Johansson, Cassia B Trewin, +3 authors, Giske Ursin.
Breast Cancer Res, 2021 Feb 03; 23(1). PMID: 33526044    Free PMC article.
Deeply-supervised density regression for automatic cell counting in microscopy images.
Shenghua He, Kyaw Thu Minn, +2 authors, Hua Li.
Med Image Anal, 2020 Dec 08; 68. PMID: 33285481    Free PMC article.
ID1 and ID4 Are Biomarkers of Tumor Aggressiveness and Poor Outcome in Immunophenotypes of Breast Cancer.
Marta Garcia-Escolano, Yoel G Montoyo-Pujol, +8 authors, Gloria Peiro.
Cancers (Basel), 2021 Jan 31; 13(3). PMID: 33514024    Free PMC article.

;. PMID: 33574272
Improved detection of sentinel lymph node metastases allows reliable intraoperative identification of patients with extended axillary lymph node involvement in early breast cancer.
Cristina L Cotarelo, Annemarie Zschöck-Manus, +4 authors, Sonja Thaler.
Clin Exp Metastasis, 2020 Nov 30; 38(1). PMID: 33249518